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Abstract 
 
Peripheral nerve regeneration often results in poor functional outcomes, a reality 
we aim to change. Injured peripheral neurons mount an intrinsic repair response as they 
undergo regenerative neuronal reprogramming, which can be enhanced by brief electrical 
stimulation (ES) of the injured nerve at the time of surgical repair, resulting in improved 
regeneration in rodents and humans.  However, this approach is invasive.   
 Acute intermittent hypoxia (AIH) - breathing alternate cycles of regular air and air 
with ~50% normal oxygen levels (11% O2) is emerging as a promising non-invasive 
intervention that promotes respiratory and non-respiratory motor function in spinal cord 
injured rats and humans. However, this therapy has the potential to globally impact the 
nervous system beyond the motor system. Of note, hypoxic conditions can increase 
neural activity in injured sensory neurons and peripheral axons and promote repair. Thus, 
I hypothesized that an AIH paradigm similar to that used for spinal cord repair, will 
improve peripheral nerve repair in a manner akin to ES, including its impact on 
regeneration-associated gene (RAG) expression – a predictor of growth states. To this 
end, alterations in early RAG expression (growth-associated protein 43, brain-derived 
neurotrophic factor, hypoxia-inducible factor alpha and a neural specific growth-
associated protein, superior cervical ganglion 10) were examined for rats that had 
undergone tibial nerve transection and repair with either 2 days of normoxia treatment or 
AIH treatment begun two days post-repair, or 1 hour continuous ES treatment (20 Hz) at 
the time of repair. Three days post-repair, AIH or ES treatments effected significant and 
parallel elevated RAG expression relative to normoxia control treatment, most evident at 
the growing axon front. Behavioural, thermal and mechanical sensitivity assessments 
revealed that neither ES nor AIH elevated regeneration-associated pain states. Finally, ES 
showed significant impacts on functional recovery relative to normoxia controls in mid 
(25 day)- and late (70 day)-regeneration stages and AIH in mid (25 day)-regeneration 
stages. These indicators of an enhanced regenerative state for AIH and ES were 
supported by significantly increased numbers of newly myelinated fibers detected 20 mm 
distal to the tibial nerve repair site at 25 days post nerve repair. 
 iii 
Collectively, these results support a role for brief AIH treatment, as a promising 
noninvasive adjunct therapy for improved peripheral nerve repair in a manner consistent 
with that observed with the more invasive direct nerve stimulation. 
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1. Introduction   
A century ago, Santiago Ramón y Cajal described in his ‘Degeneration and 
Regeneration of the Nervous System’ the regenerating capability of the axons of the 
peripheral nervous system (PNS) following nerve damage. This characteristic of the PNS 
to regenerate, unlike that of the central nervous system, has lead to the generalization that 
peripheral nerves fully regrow when, in fact, only 10% of adults regain normal function 
after injury to a major peripheral nerve even with surgical intervention (Brushart et al. 
1998). Peripheral reinnervation is thus described as ‘often delayed and seldom complete’ 
(Zochodne 2012). In addition to slow growth and incomplete reinnervation, regenerating 
axons are often misdirected to functionally inappropriate target organs with efferent 
motor axons innervating sensory end organs or sensory axons being misdirected to 
inappropriate organs or locations (Brushart and Mesulam 1980, Koerber, Seymour, and 
Mendell 1989, Witzel, Rohde, and Brushart 2005). Thus, along with the diminishment or 
loss of limb or organ function, neuropathic pain states may develop.  
Despite this intrinsic ability for peripheral nerves to regenerate, it remains fraught 
with challenges often maladaptive in nature. However, the intrinsic repair mechanisms 
can be greatly enhanced by the use of alternative therapies in conjunction with surgery. 
Brief electrical nerve stimulation (ES) applied at the time of surgical repair results in 
better functional outcomes in both rodents and humans (Al-Majed et al. 2000, Gordon et 
al. 2010). However, ES is invasive and becomes difficult if the nerve is not readily 
accessible. An emerging non-invasive therapy, acute intermittent hypoxia (AIH), 
promotes respiratory and non-respiratory motor function in spinal cord injured rats and 
humans (reviewed in Dale, Ben Mabrouk, and Mitchell 2014). This AIH paradigm 
 2 
consists of breathing 5 minute alternating periods of air with half oxygen (11%) and 
regular air for ten cycles and results in increased phrenic nerve output activity in the rat 
(reviewed in Mitchell and Johnson 2003). The impact of this AIH treatment paradigm is 
presumably systemic with recent studies showing regeneration-associated changes in 
non-respiratory motor neurons in spinal cord injured rats (Satriotomo et al. 2016).  In 
addition to that documented in the central nervous system, impacts in the PNS have been 
observed. Using a more aggressive AIH protocol (10 min cycles of air with significantly 
reduced oxygen (8%) alternating with regular air for 6 cycles) begun immediately at the 
time of sciatic nerve crush, positive effects of AIH were observed on transcriptional and 
regeneration-associated (RAG) expression and the regenerative capacity of the nerves in 
mice at the early 3 day time-point examined (Cho et al. 2015). While the Cho et al. 
(2015) study demonstrated the potential for AIH in enhancing early regenerative 
responses and also revealed a direct involvement of hypoxia-inducible factor-1α  (HIF-
1α) in regulation of these responses, the level of hypoxia employed in this study falls 
within what is considered a severe hypoxia range (reviewed in Astorino, Harness, and 
White 2015). Also, the injury and treatment paradigm employed do not address the 
realities of human application, such as level of hypoxia tolerated by humans and clinical 
pathologies requiring nerve coaptation.  To this end, at the time of the Cho et al. (2015) 
publication, we had already begun studies examining whether a more subtle 2 day 
treatment of AIH using oxygen levels of 11%, similar to that currently employed in 
spinal cord injured patients, might prove beneficial to the more clinically relevant 
challenge of repairing completely severed peripheral nerves requiring coaptation, with 
treatment begun in a delayed manner. These studies were conducted in parallel with 1 
 3 
hour ES, which although being a more invasive therapeutic intervention, is one that has 
been shown to promote enhanced peripheral nerve regeneration in both rodents and 
humans and to induce changes in RAG expression in motor neurons shown to be elevated 
in response to AIH (Gordon, Brushart, and Chan 2008, Gordon et al. 2009, Gordon et al. 
2010, Satriotomo et al. 2016). Thus, my thesis reports these findings and discusses the 
potential of employing this AIH approach as a therapeutic intervention for peripheral 
nerve repair.  
 
1. Introduction to the peripheral nervous system   
The central nervous system consists of the brain and spinal cord with the PNS 
comprised of the cranial nerves and spinal nerves (reviewed in Snell 2010). The latter is a 
complex network of specialized cells and supporting elements that effectively and 
efficiently serve as a communication relay transmitting signals to and from parts of the 
body and the central nervous system (Figure 1.1; reviewed in Snell 2010). The major 
divisions of the PNS are the autonomic, somatic motor and sensory nervous systems. The 
autonomic nervous fibers innervate the arrectores pilarum muscles, the blood vessels and 
the sweat glands; the somatic motor fibers send axons to the motor end plates in skeletal 
muscles while the sensory fibers terminate in skin, tendons, muscles and joints (reviewed 
in Blumenfeld 2011). All spinal nerves are ‘mixed’ nerves in that they contain both 
somatic motor and sensory fibers. Signals along these fibers are conveyed via action 
potentials established by ionic gradients across the neuronal membrane.  
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Figure 1.1 Anatomical representation of peripheral nervous system components (© 
Stephanie Ramirez, reproduced with permission). Sensory afferents in the dorsal roots 
enter into the dorsal/posterior side of the spinal cord, with the fibers largely terminating 
in the regions referred to as the dorsal horns. The cell bodies of the sensory nerves are 
located just outside the spinal cord in a structure known as the DRG, which are dorsal to 
the sympathetic ganglia chain. The motor neuron cell bodies and their efferents housed in 
the ventral horn, exit the spinal cord on the ventral/anterior side via the ventral roots. The 
fibers from the motor, sensory and sympathetic components join together to form the 
spinal nerves, which then go on to join and form the various peripheral nerves.  
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1.2 Functional anatomy of the peripheral nerve 
 Action potentials are propagated along the smallest anatomical subunit of the 
nerve, the nerve fiber or axon (Figure 1.2.1). A delicate matrix known as the 
endoneurium surrounds groups of these nerve fibers or axons to form fascicles, the 
innermost layer of the peripheral nerve (reviewed in Daroff et al. 2015). Each fascicle is 
held together by a membrane known as the perineurium that maintains intra-fascicular 
pressure and delineates the second anatomical layer. The innermost portion of the 
epineurium encloses groups of fascicles, facilitating the gliding of fascicles in relation to 
one another, while the external portion of the epineurium protects the entire nerve from 
longitudinal stress, forming the outermost layer of the nerve. Understanding these various 
layers is important especially in determining the extent of peripheral nerve injuries; the 
individual degrees of the classification system, used by clinicians to ascertain treatment 
and outcome, are demarcated by damage to the endoneurium, perineurium or epineurium 
(discussed in Section 1.5). 
The sciatic nerve is the largest nerve in the body and innervates a large portion of 
the hind limb. In the rat, it is composed of afferent sensory axons originating from the L3 
to L6 dorsal root ganglion (DRG) neurons with some variability amongst strains and 
individual animals (Asato et al. 2000, Rigaud et al. 2008) and efferent motor axons  
originating from spinal motor neurons located within spinal cord segments L3/L4 to S2 
(Janjua and Leong 1984). An injury to any portion of the sciatic nerve or its branches will 
therefore affect motor and/or sensory function and generate an axonal retrograde 
response in the associated DRG and spinal cord neurons.  
The sciatic nerve splits just proximal to the popliteal fossa into three branches: the  
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Figure 1.2.1 Schematic of peripheral nerve anatomy. Once the nerve exits the 
intervertebral foramen at the level of the vertebral column, the arachnoid and dura merge 
to form the epineurium. The outer portion known as the epineurium (light blue gray) 
helps to absorb longitudinal stress on the nerve. The connective tissue of the epineurium 
surrounds blood vessels (red) that supply the nerve. Some smaller branches of these 
blood vessels penetrate into the sheath that groups the axons of each fascicle together 
known as the perineurium (gray). Within these fascicles, the endoneurium (white) is the 
delicate matrix present between individual axons (blue), which acts as a structure to 
support a mesh-like network of blood vessel capillaries. Peripheral axons with a diameter 
greater than 1 µm are myelinated. Schwann cells (green) produce myelin as a spiraled 
sheet of cellular membrane and each Schwann cell makes one segment of myelin. There 
is discontinuity between each myelin segment and this space is known as a ‘node of 
Ranvier’.  
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largest being the tibial nerve, the second, the common peroneal nerve and the smallest 
being the sural nerve. The tibial continues behind the knee then the first branch 
innervates the medial gastrocnemius muscle, then a large branch innervates the lateral 
gastrocnemius, soleus and plantaris muscles and another large branch innervates the 
posterior tibialis, flexor hallucis longus and the flexor digitorum longus muscles (Badia et 
al. 2010). The tibial then continues intact until it reaches the level of the ankle where it 
splits into two terminal branches, the medial plantar nerve and the lateral plantar nerve 
(Figure 1.2.2; Badia et al. 2010).  
 
1.3 Motor neurons 
 Voluntary mechanical movement of the body relies on the efferent component of 
the nervous system, the motor system. The motor system is charged with relaying a 
multitude of impulses to a wide variety of muscles. These impulses are initiated by lower 
somatic motor neurons whose cell bodies are either situated in the ventral horn of the 
spinal cord grey matter or in the case of the cranial nerves, in the motor nuclei of the 
brainstem. The lower somatic motor neurons are the final conduit for transmitting signals 
to the musculature and this signaling activity can be modulated by a variety of inputs. 
The first of these inputs is the upper motor neurons, influencing the lower motor neurons 
by contacting local circuit neurons in the brainstem and spinal cord, which in turn 
synapse onto a specific grouping of lower motor neurons (reviewed in Blumenfeld 2011). 
These upper motor neurons have their cell bodies located in either the brain cortex or 
other brain structures including the superior colliculus, vestibular nucleus or the reticular  
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Figure 1.2.2 In situ anatomy sciatic nerve with tibial nerve and its branches 
highlighted (Badia et al. 2010, reproduced with permission). (A) Photomicrograph of the 
rat sciatic nerve (of the left hind limb) in the thigh, with indication of the proximal, 
middle, and distal levels. The sciatic nerve divides in the mid-segment into tibial, 
peroneal, and sural nerves that separate proximal to the popliteal space. (B) 
Photomicrograph of the dissected rat sciatic nerve in the leg, from the knee (top) to the 
ankle (bottom), showing the tibial nerve branches which innervate the medial 
gastrocnemius muscle (MG), the lateral gastrocnemius (LG), soleus (S) and plantaris (P) 
muscles, and the tibialis posterior (TP), flexor halluces longus (FHL) and the flexor 
digitorum longus (FDL) muscles. The tibial then continues intact until it reaches the level 
of the ankle where it splits into two terminal branches, the medial plantar nerve (mpn) 
and the lateral plantar nerve (lpn). 
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formation. The second of these inputs is the sensory neurons as they also terminate on 
these local circuit neurons, thus mediating lower somatic motor neuron activity. 
The lower somatic motor neuron is multipolar (Figure 1.3). Although their cell 
bodies are mostly found in the ventral horn of the spinal cord within the central nervous 
system, lower motor neurons are considered to be part of the PNS because their axons 
project to the periphery of the body to form part of the spinal nerves and innervate 
skeletal muscles. There are three types of motor neurons: alpha, beta and gamma. These 
three types of neurons have significantly different conduction velocities of their action 
potentials owing to different axonal properties (Villiere and McLachlan 1996, reviewed 
in Millan 1999). Alpha motor neurons initiate contractions of the extrafusal fibers of 
skeletal muscle at a very fast rate, with a conduction velocity of 70-120 m/s, owing to 
their large axonal diameter (12-20 µm), which is highly myelinated. Beta motor neurons, 
medium in size with an axonal diameter of 5-12 µm and a conduction rate of 30-70 m/s, 
and gamma motor neurons, smaller in size with an axonal diameter of 3-6 µm and a 
conduction rate of 15-30 m/s, both innervate the intrafusal fibers of muscle spindles 
which serve as proprioceptive sensory organs to detect changes in the length of a muscle 
with beta motor neurons having some collaterals to extrafusal skeletal muscle fibers. 
 
1.4 Sensory neurons  
 The perception of one’s environment relies directly on the afferent component of 
the nervous system, the sensory system. The sensory system is charged with relaying a 
variety of sensations such as proprioception, mechanoception and nociception and thus, 
consists of a heterogeneous population of neurons. The cell bodies of these neurons are 
 10 
  
 
 
 
 
 
 
Figure 1.3 Schematic representation of a somatic motor neuron.  Somatic motor 
neuron cell bodies are housed in the spinal cord and innervate skeletal muscle tissue. 
They receive information peripherally from target tissues or centrally via their dendrites 
or cell bodies. The axon hillock is a specialized unmyelinated region that is involved in 
action potential generation.   
 
 
 
 
 
 
 11 
situated in structures located just outside the spinal cord parenchyma called the DRG 
(Figure 1.1). A single pseudounipolar process extends from the cell body of each neuron, 
and this branches into two axonal processes: one projects distally to the peripheral tissues 
and the other branches centrally to terminate within the dorsal horn of the spinal cord or 
within the brainstem nuclei via the dorsal columns (Figure 1.4). Sensory information is 
consequently transmitted from the peripheral tissues to the brainstem and then onwards to 
the thalamus, cerebellum and cerebral cortex. This directly influences both an organism’s 
perception and response to external stimuli (reviewed in Kandel, Schwartz, and Jessell 
2000).   
The sensory system is comprised of subpopulations of neurons that express 
different receptors, allowing response to different types of stimuli. Thus, sensory neurons 
are commonly classified by the type of stimulus that activates them: proprioceptive, 
mechanoreceptive or nociceptive. These three types of neurons are not necessarily 
distinct subpopulations, but in general have significantly different conduction velocities 
of their action potentials owing to different axonal properties (Villiere and McLachlan 
1996, reviewed in Millan 1999). Proprioceptive neurons’ axons are known as A-α fibers, 
are large in diameter (12-20 µm), are highly myelinated and have a conduction velocity 
of 70-120 m/s. Mechanoreceptive neurons’ axons known as A-β fibers, are medium in 
diameter (5-15 µm), are myelinated and have a conduction velocity of 30-100 m/s. 
Lastly, nociceptive neurons’ axons can be subdivided into two groups: the first are known 
as A-δ  fibers, are small in diameter (2-6 µm), are myelinated and have a conduction 
velocity of 12-30 m/s and the second, known as C fibers, are very small in diameter (0.4-
1.2 µm), are unmyelinated and have a conduction velocity of 0.5-2.0 m/s. The cell bodies  
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Figure 1.4 Schematic representation of a primary sensory neuron. The sensory 
neuron is pseudo-unipolar in structure.  One apparent process extends from the cell body 
and then branches into the peripheral process/axon that projects to the periphery of the 
body and the central process/axon that projects to the spinal cord and sometimes to the 
brain as well. Some of these sensory neurons have myelinated axons (as shown above), 
while others do not. All sensory neuron cell bodies are encapsulated by supporting 
perineuronal/satellite glial cells unique to the PNS. 
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of the sensory neurons are mostly aggregated along the periphery of the DRG structure 
with their processes located more medially.  In parallel with the diameters of their axons, 
the cell bodies of the various sensory neurons can roughly be separated by their 
diameters: proprioceptive neurons are ~40-80 µm, mechanoreceptive are ~25-40 µm and 
nociceptive neurons are ~10-25 µm, with some overlap between the three (Crowley et al. 
1994, Smeyne et al. 1994).  For example, there are some small-medium sized cells that 
are low threshold mechanoreceptors and some medium-large cells that are nociceptors 
(Djouhri et al. 2003, Fang et al. 2002). 
The PNS contains two well-known types of glial cells, Schwann cells and 
perineuronal satellite glial cells, and a few poorly characterized cells that resemble 
microglia and less differentiated Schwann cells.  A large portion of the Schwann cells 
envelop the axons of the majority of neurons, specifically those with an axonal diameter 
greater than 1 µm, producing an insulating substance called myelin, which increases the 
conduction velocity of action potentials (reviewed in Jessen and Mirsky 2005). Each 
Schwann cell ensheaths only a small segment of one axon. The smaller axons remain 
unmyelinated and lie in grooves created by the membrane of a category of Schwann cells 
that are non-myelin forming. 
  The satellite glial cells encapsulate the cell body of each sensory neuron within 
the DRG structure, forming a cellular envelope (Hanani 2005, reviewed in Pannese 1981) 
usually one to three layers thick (Pannese 1960) allowing the diffusion of most molecules 
(Shinder and Devor 1994). These satellite glial cells are also present in the autonomic 
nervous system, in both sympathetic and parasympathetic ganglia. 
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1.5 Peripheral nerve repair 
 Prior to the last century, over a period of 2000 years, neuroanatomical knowledge 
was limited and reports of peripheral nerve regeneration were correspondingly sparse 
(reviewed in Battiston et al. 2009). As far back as ancient Greece, Hippocrates of Kos 
warned physicians of nerve injuries when attempting to mend soldier’s dislocated 
shoulders (460-370 BC). In Aelius Galenus’ writings in the 2nd century, the first reports 
of peripheral nerve repair and regeneration appeared. In the 7th century, Paul of Aegina 
reported suturing of nerves as well as Islamic physicians Muhammad ibn Zakariya al-
Razi and Ali Abu Ibn Sina in the 9th and 10th century respectively and a Catholic monk, 
Gabriele Ferrara, provided a thorough written description of his nerve suturing technique 
in the 17th century (reviewed in Battiston et al. 2009), proposed by some as the birth date 
of nerve repair (Artico et al. 1996).  
 Unfortunately, despite this early anatomical and surgical knowledge of the PNS, 
the consensus before the 19th century was that amputation or no intervention was the best 
option for peripheral nerve injury, as nerves typically did not regenerate. The first 
landmark studies to publish findings about peripheral nerve regeneration were both in 
1915, during World War I, by French neurologist Jules Tinel and on the opposite side, 
Paul Hoffman, a German physiologist (Hoffmann, Buck-Gramcko, and Lubahn 1993). 
They developed a technique to detect irritated nerves by lightly tapping over the nerve to 
elicit a tingling sensation/paresthesias, known as the Hoffman-Tinel sign and still used 
today to detect entrapment of either the median nerve within the carpal tunnel or the ulnar 
nerve in the postcondylar groove. Based on reports ascertained during World War II by 
Sir Herbert Seddon (1954, 1948a, b) and his various colleagues, he published the first 
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classification system of peripheral nerve injuries, dividing them into three distinct types: 
neurapraxia, a temporary loss of nerve conduction that fully recovers within days to 
weeks with the endoneurium, perineurium and epineurium remaining intact; axonotmesis, 
no nerve conduction distal to the injury site with some axonal regeneration possible 
without surgical intervention, epineurium remains intact ; neurotmesis, no nerve 
conduction distal to the injury site, no regeneration possible without surgical intervention, 
partial or complete severance of endoneurium, perineurium and epineurium. In 1951, Sir 
Sidney Sunderland published his findings on the topographic organization of peripheral 
nerves and later on, his 5 degrees of nerve injury classification system (Sunderland 1978) 
which is still used by surgeons today:  
- 1st degree: equivalent to neurapraxia 
- 2nd degree: equivalent to axonotmesis 
- 3rd degree: axonotmesis with endoneurium injury 
- 4th degree: axonotmesis with perineurium injury 
- 5th degree: equivalent to neurotmesis 
- 6th degree: suggested by MacKinnon and Dellon (1988) as one that combines 
several of these degrees of injuries per fascicle and one that is the most 
frequently seen clinically 
The main challenge of most surgical repairs of severed axons is attempting to 
restore the continuity between the proximal and distal stumps, known as end-to-end 
repair. Four main steps are undertaken (reviewed in Griffin et al. 2014): 1) preparation of 
the nerve ends to remove necrotic tissue, 2) approximation of the nerve ends while trying 
to avoid tension (repairs without tension have better outcomes), 3) rotational alignment of 
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the nerve ends taking the blood vessels into account, and 4) maintenance by using 9-0 or 
10-0 non-absorbable suture to perform an epineurial repair or individual fascicular groups 
in the case of larger nerves. If the nerve ends cannot be approximated without significant 
tension, grafts are required. Autologous grafts are typically used as they are harvested 
from the patient’s own body but are limited in amount and create complications at the 
donor site. Unfortunately, the standard grafts are the medial antebrachial cutaneous or the 
sural nerves, both sensory, when outcomes could be significantly improved with the 
architecture of motor nerve grafts (Moradzadeh et al. 2008). To meet this need, 
decellularized nerve allografts have recently become available (reviewed in Szynkaruk et 
al. 2013). These decellularized nerve allografts have been supplemented with stem cells 
(Wang et al. 2012), Schwann cells (Santosa et al. 2013) and growth factors (Boyer et al. 
2015, Tajdaran et al. 2016). Another product used to bridge a short injury gap is 
polyethylene glycol. By exposing the proximal and distal axonal ends to a saline solution 
without calcium (Ca2+) while trimming them to then fuse them with polyethylene glycol, 
it helped restore short- and long-term function in addition to preventing some distal axon 
disintegration known as Wallerian degeneration (See Section 1.5.1; Ghergherehchi et al. 
2016).  
In this thesis, all nerve injuries involve complete transection of the tibial nerve in 
rats and are therefore classified as 5th degree or neurotmesis. An end-to-end epineurial 
repair was performed using 10-0 suture within a 4 mm silastic tube. The factors that 
influence the level of success of nerve repairs are age, time of primary repair, 
regeneration distance, proprioceptive feedback and rehabilitation. As surgical repair 
techniques and treatments create a more favorable regenerative microenvironment and 
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improve the coaptation region that the regenerating axons must traverse, the distance 
regenerating axons must travel, from injury region to target, remains the same and a 
definite challenge. Thus, recent therapies, including approaches used in this thesis, focus 
on modulating the neurobiological axes of Wallerian degeneration, cellular injury and/or 
regeneration responses in an effort to improve regenerative outcomes in the least invasive 
way. 
 
1.5.1 Peripheral nerve regeneration 
 Following a nerve crush or a transection injury, the distal axons are separated 
from their cell bodies and undergo a process known as Wallerian degeneration where 
they begin to disintegrate within their endoneurial tubes (Waller 1850). The initial injury 
initiates a transient local Ca2+ wave that travels into the proximal stump and the distal 
axon fragment, disrupting the mitochondria within the vicinity. This initial Ca2+ wave, 
along with others produced if subsequent injuries are inflicted, was shown to not be 
necessary to induce the degeneration process of the distal axon fragment (Vargas et al. 
2015). In contrast, the terminal phase of Ca2+ influx, affecting the cytoplasm and 
mitochondria of the entire axon, precedes the degeneration of the distal axon fragment by 
minutes. If blocked, this process is either delayed or significantly reduced (Vargas et al. 
2015). 
In response to injury, Schwann cells dedifferentiate/become activated as part of an 
adaptive response that facilitates nerve regeneration. They initially participate in the 
clearance of myelin and disintegrated axonal fragments within the first few days, 
eventually being replaced by infiltrating macrophages (Gaudet, Popovich, and Ramer 
 18 
2011). More recently a study by Gomez-Sanchez et al. (2015) has revealed that the 
Schwann cells actually digest the myelin through a novel form of selective autophagy 
that is referred to as myelinophagy, a property of peripheral but not central myelinating 
cells, as transected optic nerve showed little evidence of autophagy. The Schwann cells 
are key players in the regeneration process as they undergo mitosis to form a structure to 
support the regenerating axons along the remnants of endoneurial sheaths, with the 
Schwann cells aligned as structures known as bands of Büngner. During regeneration, 
Schwann cells promote axon growth through the production of extracellular matrix 
molecules and increased levels of chemokines, cytokines and growth factors, the latter 
including nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), 
neurotrophin 4/5, vascular endothelial growth factor, pleiotrophin, artemin and glial-
derived neurotrophic factor (GDNF) as well as expression of the common neurotrophin 
receptor p75 and the cell adhesion molecule N-cadherin (reviewed in Jessen and Mirsky 
2016). There is a coordinated series of events that enables the injured axon to regenerate 
into the Wallerian degenerating distal portion of the injured nerve, with delays in the 
repair further challenged by a waning responsiveness of this region to support axon 
regeneration (reviewed in Fu and Gordon 1995).  
 
1.5.2 Regeneration-associated genes 
In order for regeneration to commence post-peripheral nerve injury, there is a 
major shift in gene expression, collectively known as the cell body response, that must 
occur in the injured sensory and motor neurons, whereby a class of genes known as 
RAGs becomes significantly upregulated. These RAGs include activating transcription 
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factor 3 (ATF3), growth-associated protein 43 (GAP43), the cytoskeletal proteins tubulin 
and actin, superior cervical ganglion 10 (SCG10; aka stathmin 2) in sensory neurons, 
BDNF and its high-affinity receptor, NTRK2, more commonly referred to as trkB, in 
motor neurons ((reviewed in Verge et al. 1996, Zochodne 2012, Shin, Geisler, and 
DiAntonio 2014).  
Following a nerve injury, ATF3 is rapidly upregulated in sensory and motor 
neurons in both rats and humans (Tsujino et al. 2000, Gey et al. 2016). It is considered an 
excellent marker for neuronal injury as it cannot be induced trans-synaptically (Tsujino et 
al. 2000). The induction of approximately 20 to 25% of RAGs have been shown to be 
dependent on ATF3 levels (Gey et al. 2016).  
In rats at birth, GAP43 mRNA is present in high levels in both spinal cord motor 
neurons and DRG neurons (Chong et al. 1992). This persists for seven days postnatal, 
followed by a decline to adult baseline levels. In a non-injured adult rat, GAP43 is 
expressed at low levels in the lumbar motor neurons with substantial labeling of the 
neuropil (Schreyer and Skene 1991, Chong et al. 1992). Peak levels of GAP43 in the 
lumbar motor neurons were observed 3 days after a sciatic nerve transection (Chong et al. 
1992). In the uninjured DRG, a mean of 46% of the neurons in L4 and L5 ganglia display 
some degree of GAP43 immunohistochemical labeling (Schreyer and Skene 1991). Most 
are lightly labeled by immunohistochemistry with the highest level of mRNA expression 
generally being found in the small/medium sensory neurons (Verge et al. 1990). A high 
proportion of the sensory neurons in the L4 and L5 DRG, over 80%, express GAP43 after 
a sciatic nerve injury (Verge et al. 1995, Schreyer and Skene 1991).  
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SCG10 is an axonal maintenance factor that is highly expressed during the 
development of the nervous system as it regulates protein transport and microtubule 
stability (reviewed in Ozon, Maucuer, and Sobel 1997). After development, it is 
expressed as a punctate pattern throughout the peripheral nerves whereas after an injury, 
its expression pattern changes dramatically (Shin, Geisler, and DiAntonio 2014). Only 3 
hours post-injury, levels of SCG10 decrease by more than 70% in the distal nerve stump 
whereas degeneration of the axons is only observed after 48 hours (Beirowski et al. 2005, 
Shin et al. 2012). In contrast, on the growing axon front, SCG10 levels rise dramatically 
within half an hour, continue to rise until 3 hours where they plateau and at 5 hours, 
labeling can be observed in the central region of individual growth cones (Shin, Geisler, 
and DiAntonio 2014). The mechanism underlying this phenomenon appears to be the 
continuous anterograde transport of SCG10, replenishing protein levels within the axon 
from the cell body at a rate of 1.16 µm/s (Shin et al. 2012). The severance of this conduit 
would lead to the accumulation of SCG10 in the growing axon front. Thus, SCG10 can 
be used as a very early marker for peripheral nerve injuries with preferential expression 
in sensory versus motor axons, elevated in the proximal stump and reduced in the distal 
stump, when at those early time-points of 4 or 8 hours for example, GAP43 expression 
levels remain moderate (Shin, Geisler, and DiAntonio 2014). 
BDNF plays a crucial role in plasticity promoting sprouting and regeneration of 
the PNS. Unlike the other neurotrophins, BDNF expression rises sharply in ~80% of 
sensory neurons following a nerve injury, followed by a reduction in expression in the 
small, NTRK1, more commonly referred to as trkA, expressing nociceptive population 
and an induction in the medium to large, NTRK2 and/or NTRK3 (also commonly known 
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as trkC) expressing population (Karchewski et al. 2002). The rapid increase in BDNF 
expression in the majority of sensory neurons is critically linked to the ability of these 
neurons to transition to a regenerating state (Geremia et al. 2010) while the induction in 
larger size neurons aids in remyelination of the regenerating nerves. BDNF promotes 
myelination during both development and after an injury via the common neurotrophin 
receptor p75 present in sensory neurons, injured motor neurons and Schwann cells in 
vitro and in vivo (Chan et al. 2001, Cosgaya, Chan, and Shooter 2002, Zhang et al. 2000).  
Another molecule, GDNF, a member of the transforming growth factor β family, 
also has trophic effects on motor neurons and some sensory neurons, despite being 
structurally different from the neurotrophin family, thus is in a class of its own. It acts 
primarily on the ~40% of small and large sensory neurons that express the GDNF 
receptors RET and GFRα (Bennett et al. 1998, reviewed in Baloh et al. 2000). GDNF 
was first purified in 1993 and it was initially believed that it was a survival factor for only 
dopaminergic neurons (Lin et al., 1993). GDNF has a strong trophic effect on Schwann 
cells and sensory neurons (Matheson et al., 1997; Naveilhan et al., 1997). However, too 
much GDNF can actually impede regeneration in neurons. The induced overexpression of 
GDNF by Schwann cells implanted into acellular nerve allografts used for nerve repair 
actually trapped regenerating axons in the graft, preventing them from reaching the distal 
stump, perhaps due to the lack of a trophic gradient to lure the axons into it (Santosa et al. 
2013).  
Of interest to our laboratories, and initially investigated by Dr. Atiq Hassan 
(2015), is a heterodimeric transcriptional RAG linked to oxygen homeostasis within the 
cell: hypoxia-inducible factor-1α (HIF-1α). HIF-1 was identified by Semenza et al. 
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(1991) when investigating transcriptional activation of erythropoietin in response to 
hypoxia. HIF-1α protein synthesis is regulated by a multitude of growth and other factors 
(reviwed in Masoud and Li 2015).  HIF-1α is quickly degraded by the ubiquitin-
proteasome system in the cell under conditions of normoxia (at atmospheric oxygen 
levels), having a half life of only approximately 5 minutes, (Salceda and Caro 1997). In 
contrast, under hypoxic conditions, HIF-1α is activated within the cell, translocated from 
the cytoplasm to the nucleus where it forms the HIF heterodimer complex protein by 
binding with HIF-1β which is constitutively expressed (Lando et al. 2002, reviewed in 
Masoud and Li 2015).    
Recent work by Cho et al. (2015) has established a link between induction of 
HIF-1α using hypoxia and the regenerative capacity of sensory neurons and 
accelerating the reinnervation of neuromuscular junctions. They demonstrated that HIF-
1α is not required for the early phase of regeneration as its absence did not hinder the 
outgrowth of SCG10-expressing axons 1 day post-crush lesion. When a conditioning 
lesion was performed 3 days prior, a 2 fold increase in axon regeneration was observed, 
supporting HIF-1α’s role as a transcriptional regulator, activating the pro-regenerative 
program. In addition to HIF-1α, the regenerative response is linked to the activation of a 
number of important transcriptional regulators including ATF3, STAT3, c-Jun and 
Luman/cAMP response element binding protein 3 (Ying, Misra, and Verge 2014, 
Zigmond 2012;, reviewed in Raivich 2011). This activation, coupled with local 
translation of proteins including cytoskeletal modifiers, neuropeptides, adhesion and 
guidance molecules, is instrumental to the growing axon quickly transitioning and 
maintaining a regenerative state (reviewed in Raivich 2011). Increases in regeneration-
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associated proteins such as GAP43 and BDNF are often associated with increased 
plasticity required for induction and mediation of the nerve regeneration (Geremia et al. 
2007, Udina et al. 2008, Bomze et al. 2001, Geremia et al. 2010). It is thus necessary to 
identify the optimal parameters for regeneration to occur in vivo, in the hopes of being 
able to recreate these ideal conditions as best as possible in clinical scenarios.  
 
1.6 Electrical stimulation and nerve regeneration 
Our laboratory and colleagues have previously employed an approach using ES to 
enhance the regenerative/plasticity capacity of peripheral nerves. The application of 
electrical current directly to the sciatic nerve post-injury at 20 Hz for one hour activates 
both sensory and motor neurons and a significant cellular response is induced. This 
response involves an influx of Ca2+ into the neurons followed by the upregulation of 
regeneration/plasticity-associated genes such as BDNF, cAMP, GAP43, tα1-tubulin, 
actin in motor and sensory neurons, and the BDNF receptor NTRK2 in motor neurons 
(Al-Majed, Brushart, and Gordon 2000, Gordon et al. 2009, Wenjin et al. 2011). These 
cellular mechanisms are believed to be responsible for the enhanced growth and target 
specificity. BDNF is thought to be upregulated with ES treatment through the activation 
of L-type voltage sensitive Ca2+ channels of the non-N-methyl-D-aspartate subtype of 
glutamate receptor (reviewed in Al-Majed, Brushart, and Gordon 2000). Another factor 
upregulated by ES, responsible for enhanced neurite outgrowth and regeneration, is 
cAMP (reviewed in Batty, Fenrich, and Fouad 2017). Drugs that increase neuronal cAMP 
levels, as well as activating phosphokinase A, promote axon proliferation akin to that 
observed with ES (reviewed in Gordon et al. 2009).  
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Initial studies were performed to identify the optimal duration and timing of ES 
therapy. When applying low frequency stimulation directly to a peripheral nerve, one 
hour has been shown to be as effective as a continuous two week protocol for motor 
neurons (Al-Majed et al. 2000). In contrast, single stimulation protocols beyond an hour 
of continuous stimulation negate the optimal positive regenerative effects of the treatment 
in sensory neurons (Geremia et al. 2007). In terms of timing, one hour of ES when 
applied successive to a sciatic nerve repair with a biodegradable conduit 1 day or 1 week 
after a nerve transection is effective at promoting regeneration. But, when performed 1 or 
2 months post-injury, a repair using the same conduit paradigm is not enhanced by ES. 
This is believed to be a consequence of distal stump degeneration and/or fibrosis due to 
increased collagen (Han et al. 2015). Comparatively, when a direct nerve-to-nerve repair 
was performed 3 months after a nerve transection, one hour of ES was still capable of 
improving axonal outgrowth and target reinnervation (Elzinga et al. 2015).  
ES also promotes earlier sprouting of neurites and more accurate reinnervation 
(Al-Majed et al. 2000, Brushart et al. 2005, Geremia et al. 2007). Collectively, the 
stimulated axons appear to grow out as a front as opposed to the staggered type of 
regrowth normally observed (Geremia et al. 2007). ES thus promotes an earlier onset of 
axons regenerating across the nerve repair site without increasing its overall elongation 
speed through the distal stump, as assessed by isotopically labeling proteins transported 
to the growing axon front (Gordon, Brushart, and Chan 2008). Further, if lumbar motor 
neurons are remotely activated by application of 1 hour of ES to the cervicothoracic 
spinal cord, regenerating motor axons of the femoral nerve show greater target specificity 
at 6 weeks post-repair (Franz et al. 2013). The effect that ES has on DRG neurons can be 
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cell autonomous, as accelerated more robust neurite outgrowth is also observed when 
DRG neurons are isolated and cultured in vitro on a microelectrode array that applies the 
same 1 hour stimulation paradigm used in our in vivo studies (Singh et al. 2012).  
Promoting regeneration into the distal nerve stump while it remains in a growth 
permissive state is a major goal of treatment. This state includes the neurotrophic support 
provided by the distal stump, which expresses a multitude of growth factors, many of 
them by Schwann cells, as well as surface adhesion molecules, and the increased 
expansion of basement membrane extracellular matrix proteins such as laminin, 
fibronectin, among many others. Because this state cannot be sustained indefinitely, one 
must be cognizant of this challenge when designing delayed nerve repair strategies or 
ones where distance to target is great (Fu and Gordon 1997).   
A complementary strategy to direct nerve stimulation has been recently 
employed, with the hopes that it will impact reinnervation of the denervated target tissue, 
namely stimulation of target tissue.  ES of the target muscle rather than the nerve directly, 
resulted in significantly increased numbers of reinnervated motor units and improved 
functional outcomes (Willand et al., 2015). Here, the gastrocnemius muscle was 
stimulated with a biphasic train of 40 pulses at 100 Hz for an hour a day, described as 
more suitable for fast twitch muscle, which elicits a contraction every 6 seconds (Willand 
et al. 2011). The improved outcomes are speculated to be influenced by the increased 
intramuscular, but not nerve levels of BDNF and GDNF mRNA (Willand et al. 2016). 
This therapy has also been shown to be sufficient in increasing the number of axons in 
the distal stump, possibly due to the support of trophic factors diffusing from the target 
muscles (Willand et al. 2016) 
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1.7 Acute intermittent hypoxia as an adjunct therapy 
Another potential therapeutic intervention that has come to light for nervous 
system repair is AIH. Intermittent hypoxia has been the focus of research in recent years 
due to its negative implications in sleep-disordered breathing and its positive effects on 
athletic performance (Berger and Lavie 2011, Wilber, Stray-Gundersen, and Levine 
2007). Therefore, it can be described as both beneficial and harmful, with the hypoxic 
dose determining the outcome. Because of exposure to chronic intermittent hypoxia over 
long periods of time, patients with sleep apnea may suffer from cognitive dysfunction, 
hypertension, and myocardial ischemia (reviewed in Chakrabarty 2006). With obstructive 
sleep apnea, the hypoxic episodes are brief but they are very frequent, with the adverse 
effects correlated with the total time patients are hypoxic (oxygen saturation <90%) 
(Gottlieb et al. 2009).  In contrast, when athletes are exposed to alternating periods of 
hypoxia and normoxia for less than 90 minutes per day, most studies, mainly endurance 
ones, but not all endurance studies, report performance improvements of 1.7 to 8.2% 
(Kilding, Dobson, and Ikeda 2016). Protocols of intermittent hypoxia vary significantly 
by a number of parameters: the severity of the hypoxic exposure (reported as the levels of 
inspired reduced oxygen also known as hypoxemia) with levels varying from 2% to 16%, 
the length of each hypoxic versus normoxic exposure ranging from 15-30 sec to 12 hours, 
the number of cycles per day recorded as 3 to 2400, the exposure schedule (consecutive 
or alternating days, number of days per week), the total experimental hypoxic exposure 
(from less than an hour to 90 days) and other variables such as the arterial carbon dioxide 
levels (reviewed in Navarrete-Opazo and Mitchell 2014). 
AIH therapy consists of repeatedly breathing low levels of oxygen for short 
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periods of time alternating with ambient levels of oxygen.  This sets up a form of 
respiratory plasticity, known as long-term facilitation (LTF), that was first observed in 
rats following three short hypoxic episodes (Bach and Mitchell 1996, Hayashi et al. 
1993). This LTF has been demonstrated in both rats and humans (McGuire et al. 2002, 
2004, Pierchala et al. 2008) and is measured by an increase in phrenic or hypoglossal 
nerve amplitude that is maintained for at least 2 hours following AIH treatment (Baker-
Herman and Mitchell 2002, Mitchell et al. 2001).  The development of LTF is 
fundamentally pattern dependent. Importantly, continual hypoxia is not capable of 
invoking LTF (Baker and Mitchell 2000), with the required stimulus appearing to be 
repetitive changes in blood levels of oxygen (Fuller et al. 2000, Mahamed and Mitchell 
2008). Varying protocols of hypoxia appear to exhibit comparable effects, as long as the 
hypoxic episodes administered are intermittent and acute (Mahamed and Mitchell 2007). 
The total length of treatment is also critical; if administered chronically, such as 5 min 
alternating episodes for 12 hours per night for a week in rats, this leads to deleterious 
consequences (Fuller et al. 2003). Therefore, investigations into hypoxic dosage to 
enhance positive and decrease negative outcomes have helped establish the optimal AIH 
parameters of 3 to 15 sequences of alternating air with modest levels of hypoxia of 9 to 
16% oxygen (reviewed in Navarrete-Opazo and Mitchell 2014), while oxygen levels in 
the 2-8% are considered a severe hypoxia range (reviewed in Astorino, Harness, and 
White 2015). 
In rats, an AIH treatment protocol consisting of only 3 to 10 hypoxic episodes in 
less than two hours per day is sufficient to elicit spinal plasticity of a relatively short 
duration in the Sprague-Dawley strain (Dale-Nagle et al. 2010, Lovett-Barr et al. 2012). 
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To increase the effects of treatment, they either treat rats with partial spinal cord injuries 
daily for 7 days (Wilkerson and Mitchell 2009, Lovett-Barr et al. 2012) or three times per 
week for 10 weeks (Satriotomo et al. 2012). These paradigms appear sufficient to induce 
spinal plasticity without obvious adverse consequences (Vinit, Lovett-Barr, and Mitchell 
2009).  
In addition to variations in AIH treatment protocol, attention should be paid to 
which inbred rat strains are used in each study as differences in phrenic responses to 
time-dependent hypoxia have been reported by Golder et al. (2005) who compared 
Brown-Norway, Fischer, Lewis and Piebald-viral-Glaxo strains. Additionally, AIH 
treatment is highly dependent on the time of its introduction post-injury and varies 
between rat strains. For example, four weeks post-injury, an AIH effect was observed in 
Lewis but not Sprague-Dawley rats (Golder and Mitchell 2005). This variability is not 
restricted to rats; genetic influences on hypoxic ventilatory response have been described 
in humans as well (Weil 2003).   
Investigations at the cellular level revealed that the initiation of LTF is dependent 
on the activation of spinal serotonin receptors (Prabhakar 2001, Baker et al. 2001) and 
that serotonin-dependent synthesis of BDNF is necessary to maintain it after AIH 
treatment (Baker-Herman and Mitchell 2002). This phenomenon appears to be 
independent of increased phrenic nerve activity and is described as a ‘form of 
neuromodulator-induced plasticity’ (Mitchell and Johnson 2003). BDNF is highly 
associated with neuroplasticity and neuroregenerative states, however its increase in 
small and medium sensory neurons is also associated with an increase in pain sensation 
known as hyperalgesia (Coull et al. 2005, Tender, Li, and Cui 2010). Elevated levels of 
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BDNF in the dorsal horn of the spinal cord of rats with an injured sciatic nerve 
correspond with the timeline of thermal hyperalgesia, increased sensitivity to a noxious 
thermal stimulus, with a return to baseline levels of BDNF correlating with a return to 
baseline thermal sensitivity after 28 days (Miletic and Miletic 2002). If AIH causes a 
significant upregulation in serotonergic signaling, it is possible that sensory neurons, in 
addition to motor neurons will be affected by the treatment. While the actions of 
serotonin in pain pathways are complex and dependent on the complement of serotonin 
receptors, increased serotonin levels in the periphery have been linked to induction of 
mechanical hyperalgesia, increased sensitivity to a force applied to the foot pad of the 
hind paw, via increases in transient Ca2+ signaling in sensory neurons (Lin et al. 2011). 
By instigating a shift in the neural environment, alterations in protein expression 
associated with novel therapies hold the potential to increase pain.  As such, the potential 
impact of AIH treatment on injury-associated mechanical and/or thermal hyperalgesia 
needs to be investigated.  
 It can also be postulated that AIH may have a systemic impact on neuronal 
activity; hypoxic conditions have been shown to increase neural activity (spontaneous 
impulse generation) in injured sensory neurons and peripheral axons (Burchiel 1984), and 
when exposed, sensory neurons produce nitric oxide to resist against the effects of 
hypoxia, a mechanism dependent on the activation of mitochondrial complex II and 
voltage gated Ca2+ channels (Henrich et al. 2004). AIH’s ability to elevate RAG 
expression in spinal cord injury models that is consistent with the gene programs induced 
in peripheral nerve regeneration in response to ES, supports investigating AIH as a 
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possible treatment modality for enhancing repair following peripheral nerve injury in a 
manner akin to ES. 
 
1.8 Rationale 
It appears that these two independent treatments, ES and AIH, may have some 
underlying commonalities in terms of how they promote repair of the nervous system, 
namely their ability to increase neural activity and associated RAG expression, including 
a major regulator of regenerative events in peripheral nerve repair – BDNF (Al-Majed, 
Brushart, and Gordon 2000, Wenjin et al. 2011, Wilkerson and Mitchell 2009). BDNF 
has been shown to be critical for the induction of a regenerative state in sensory and 
motor neurons (Geremia et al. 2010, Verge 2004). This upregulation of BDNF does 
however appear to be via different mechanisms: In the case of ES, it is speculated to be 
directly elevated through the activation of L-type voltage sensitive Ca2+ channels of the 
non-N-methyl-D-aspartate subtype of glutamate receptor (Al-Majed, Brushart, and 
Gordon 2000) or with AIH treatment, BDNF has been shown to be upregulated in a 
serotonin-dependent manner (Baker-Herman et al. 2004). The increased neural activity 
evoked by AIH, thus, may upregulate BDNF and BDNF-dependent RAGs and serve to 
promote peripheral nerve repair.  This is also supported by emerging data linking the 
hypoxia-induced transcription factor HIF-1α to downstream regulation of RAGs in the 
regenerating sciatic nerve (Cho et al. 2015).  
The delivery of these therapies clinically is also very different. ES requires the 
application of sterile stainless steel wires directly to the injured nerve at the time of 
surgery and half an hour later, once the patient has recovered from anesthetic, a 
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continuous 20 Hz train is delivered for an hour with the wires subsequently pulled out 
(Gordon et al. 2010). AIH, on the other hand, is delivered via a non-rebreathing mask 
attached to an oxygen generator that provides variable inspired oxygen mixtures 
(Trumbower et al. 2012).  
The extent to which AIH might serve as a clinically relevant adjunct therapy for 
PNS repair beyond the promising impact on phrenic nerve plasticity seen in cervical 
spinal cord injury models remained to be investigated at the start of this thesis. We 
therefore sought to identify whether AIH treatment may in fact promote regeneration in 
the PNS akin to that seen with ES, safely, without inducing mechanical or thermal 
hyperalgesia. To do so, we took a two step approach in an in vivo rat model: (i) assessing 
whether only two sessions of AIH treatment with 11% oxygen administered 48 and 72 
hours post-injury, significantly increased RAG expression within the range currently seen 
with ES after the most acute nerve injury, namely a complete nerve transection followed 
by coaptation (classified as neurotmesis or 5th degree nerve injury) and (ii) performing 
longer-term investigations to elucidate the physiological/behavioural affects of this AIH 
protocol on the regrowth of the tibial branch of the sciatic nerve in rats.  
AIH has previously been shown to improve peripheral nerve regeneration 
outcomes by Cho et al. (2015). However, our approach differs significantly from that of 
the two protocols employed by Cho et al. (2015). The first Cho protocol utilized for 
investigation of axonal regeneration consisted of 3 sessions with 8% oxygen, the first 
session administered within 2 hours of surgery with the second and third treatments after 
24 and 48 hours respectively. For studying the extent of muscle reinnervation, they used a 
second protocol - 7 consecutive days of AIH sessions with 8% oxygen beginning an hour 
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post-sciatic nerve injury. As mentioned before, 8% falls within the severe hypoxia 
treatment ranges for human applications.   
Thus, in our studies we opted to investigate a more clinically relevant model of 
nerve repair and assess responses over protracted regeneration periods and longer 
distances. We also investigated cellular responses and regeneration for both motor and 
sensory neurons.  To this end we are: (i) testing a hypoxia level within the range utilized 
in current human trials; (ii) because of the parallels of AIH with plasticity responses 
observed in regenerating motor neurons subjected to ES, we are directly comparing these 
two therapeutic interventions in a clinically relevant model of severe nerve injury - nerve 
transection and coaptation; (iii) we opted to not administer AIH until 48 hours post-
surgery as isoflurane anesthesia has been shown to increase levels of HIF-1α potentially 
confounding results with treatment effects (Li, Zhu, and Jiang 2008); and (iv) we are 
examining the impacts of the two treatments on behavioral pain and regeneration 
responses, as this is important for patient compliance. 
  
 33 
2. Hypothesis and Specific Aims 
Supported by the data presented in the introduction, I hypothesize that AIH will 
serve as an effective adjunct therapy to promote improved regeneration of surgically 
repaired peripheral nerves in a manner akin to that observed with brief nerve ES. 
 
2.1 Specific Aims 
To test this hypothesis, I addressed the following aims: 
(i) Examine the impact of AIH versus ES on early expression of early RAG 
proteins in regenerating tibial nerve and associated motor and sensory 
neurons, and examine whether there are rat strain-dependent differences in 
this response; 
(ii) Examine the impact of AIH versus ES on tibial nerve regeneration; and 
(iii) Examine the impact of AIH versus ES on regeneration- and pain-associated 
behavioural responses. 
To address these aims I: 
(a) Quantified the early expression of regeneration-associated proteins at the short-
term time-point of 72 hours post-repair of a tibial nerve transection subjected to 
immediate 1 hour ES, 2 days of AIH or normoxia treatment. This included 
examination of BDNF, GAP43 and HIF-1α expression in the injured and non-
injured motor neurons; BDNF, GAP43 and HIF-1α expression in the injured and 
non-injured sensory neurons in the L4 DRG; BDNF, GAP43 and SCG10 
expression in the proximal tibial nerve at the repair site. 
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(b) Evaluated regeneration at the mid-term regeneration time-point of 25 days. This 
included assessment of functional behavioural responses (ladder crossing test, 
walking footprint analysis, mechanical and thermal hyperalgesia tests), as well as 
the numbers of neurons regenerating 20 mm from the repair site with ES, 2 days 
of AIH or normoxia; quantification of the numbers of regenerating motor and 
sensory neurons versus total numbers of neurons contributing to the tibial nerve at 
the level of injury using a retrograde tracer introduced 28 mm distal from the 
repair site in injured rats or at the level of the injury site in naïve rats respectively; 
and assessment of the numbers of myelinated axon profiles detected 20 mm from 
the repair site in semi-thin transverse sections of nerve from the two experimental 
(AIH, ES) versus normoxia control animals; and 
(c) Assessed regeneration functionally (ladder crossing test, walking footprint 
analysis, mechanical and thermalhyperalgesia) up to the long-term regeneration 
time-point of 10 weeks post-repair of a tibial nerve transection in the two 
treatment (AIH and ES) versus control (Normoxia or no injury) groups. 
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3. Materials and Methods 
 
All animal procedures were approved by the University of Saskatchewan’s 
Committee on Animal Care and Supply under the guidelines of the Canadian Council on 
Animal Care (protocol #19980012). A total of 134 rats, 45 male Wistar strain, 4 male 
Sprague Dawley strain and 85 male Lewis strain (Charles River Laboratories, 
St.Constant, QC) weighing 250–300g, between 3 to 5 months old, were used for the 
following set of experiments. All animals upon arrival were housed at the Animal Care 
Facility in the Western College of Veterinary Medicine at the University of 
Saskatchewan and acclimated for 7 days before handling or any procedures. They were 
then evenly distributed into experimental groups based on their weights. They were 
housed in groups of 2 or 3 per cage except for post-surgery where they were singly 
housed for 4 days to allow for post-operative observation and treatment. The Animal 
Care Facility maintained a controlled environment with a temperature of 20 +/- 1 degrees 
Celsius and an alternating 12 hour light/dark schedule. The cages measured 51 cm long 
by 28 cm wide with wood chip bedding. Environmental enrichment included hard wood 
blocks, willow sticks, Nylabone® toys and newspaper. Regular introduction of new 
enrichment items were deemed necessary for hind limb nerve injuries to reduce the 
incidence of autotomous behaviour. No autotomy was observed with any of the studies. 
Rats were fed rodent rat chow ad libitum upon arrival until they reached an average 
weight of 300 grams. Afterwards, they were fed 4-5 pellets each per day in order to slow 
their weight gain and allow for a more homogenous weight distribution over the longer 
experimental timelines. 
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3.1 Tibial nerve transection and repair 
Animals were anesthetized with a gas mixture of 1.5-2.5% isoflurane/97.5-98.5% 
oxygen and given an analgesic, buprenorphine (Temgesic, sc, 0.1-0.2 mg/kg), post-
surgically for 24 hours. Under aseptic conditions, the right sciatic nerve was exposed by 
splitting the gluteal muscle and gently spreading it apart with blunt tip scissors. The tibial 
nerve, once freed of surrounding tissue, was cleanly transected with Vanna micro scissors 
5 mm distal from the sciatic trifurcation. The tibial nerve was then repaired under 40x 
magnification using 10-0 (Perma-Hand®) silk suture through the distal and proximal 
epineuriums to join the ends in the center of a 4 mm long section of Silastic® tubing 
(Dow Corning Inc., USA). The wound was then closed in layers with the muscles being 
sutured (5-0 Vicryl®) followed by the skin (4-0 Silk, Ethilon®) (See Figure 3.1.1).  
Procedure times were adjusted such that all treatment groups including ES were 
anesthetized for a similar total amount of time, ranging from an hour to an hour and thirty 
minutes total. 
 
3.1.1 Electrical stimulation 
For rats being treated with electrical stimulation, the sciatic nerve, 5 mm proximal 
to the trifurcation was cleared of surrounding tissue immediately after the tibial nerve 
transection and repair. The cathode stainless steel wire whose insulation is removed at the 
end was looped around the sciatic nerve whereas the anode wire was placed under the 
skin proximal to the surgical site. Electrical stimulation of supramaximal pulses (100 µs, 
3V) delivered in a continuous 20-Hz train was applied for an hour. The wound was then 
closed as described above.  
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Figure 3.1.1 Experimental model used to examine impact of treatment on tibial 
nerve regeneration. A complete transection of the tibial nerve was done 5 mm distal 
from the sciatic nerve trifurcation followed immediately by a repair with suture and a 4 
mm silastic cuff. Experimental treatments included either immediate nerve stimulation 
for one hour at 20 Hz (ES), or once daily normoxia (Norm) or AIH treatments for two 
days post-surgical repair. Tissue collected for regeneration analysis included the region of 
the spinal cord receiving tibial nerve inputs from L3-L5 sensory neuron afferents and 
sectioned longitudinally through the ventral horn to identify back-labeled motor neurons, 
the L4 DRG containing the majority of the tibial nerve sensory neuron cell bodies, the 
tibial nerve repair site and regions of nerve 20 mm distal to the tibial nerve repair site. 
The impact of treatment on early regeneration responses was done on tissue collected 3 
days post tibial nerve repair. Retrograde labeling of regenerated sensory and motor 
afferents with FG was performed at 25 days post-tibial nerve repair 28 mm from the 
repair site, followed by perfusion and tissue collection 5 days later.  
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3.1.2 Acute intermittent hypoxia and normoxia 
 Rats were treated on day 2 and day 3, but not on day 1 to allow for recovery from 
isoflurane anesthetic, after the tibial nerve transection and repair surgery for all 
experimental timelines. They were individually placed in custom-made plexiglass 
chambers (WD Plastics, Saskatoon, SK) measuring 30 cm long by 17 cm wide by 12 cm 
high with brown paper towel on the floor (Figure 3.1.2). The AIH protocol is automated 
via a controller and delivers continuous gas flow of medical air (21% O2) for 5 min, 
alternating with low oxygen (11% O2) for 5 min with each switch preceded by a 1 min 
purge. The daily treatment protocol consists of 10 full cycles, a total duration of 2 hours. 
For the normoxia group, continuous medical air (21% O2) flows into the chambers for the 
same duration as the AIH treatment group. The oxygen and carbon dioxide levels in the 
chambers were regularly monitored using a portable oxygen analyzer (Model AX300-1, 
Teledyne Analytical Instruments).  
 
3.1.3 Experimental timelines 
Short-term timeline 
 The impact of treatment on early regeneration responses was done on tissue 
collected 3 days post tibial nerve repair (Figure 3.1.3.1). All animals underwent a tibial 
nerve transection and repair at day 0 with 6 animals being treated with the ES treatment 
protocol immediately afterwards, 6 animals treated with the normoxia protocol on day 2 
and 3 and the remaining 6 animals treated with the AIH protocol on day 2 and 3. All the 
animals from the 3 treatment groups (n=18) were perfused one hour after completion of 
the AIH/normoxia treatment protocol on day 3 (~72 hours post-repair). Tissues from the  
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Figure 3.1.2 AIH and normoxia treatment chambers. Custom-made plexiglass 
chambers with clear lids are connected to gas cylinders via a digital controller that 
regulates air cycles. Half of the chambers are used for normoxia treatment which feeds 
continuous medical air (21% oxygen), while the other half are for AIH treatment with the 
controller set to deliver 5 minutes of alternating medical air (21% oxygen) and 5 minutes 
of low oxygen air (11% oxygen) preceded by a 1 min purge for each for a total of 10 
cycles. 
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Figure 3.1.3.1 Experimental timeline - summary of methodology used to investigate 
the short-term effect of AIH or ES on RAGs. All animals underwent tibial nerve 
transection and repair at day 0. Top: Six animals were treated with the normoxia 
treatment protocol (orange) on day 2 and day 3. Middle: Six animals were treated with 
the AIH treatment protocol (green) on day 2 and day 3. Bottom: Six animals were treated 
with ES treatment protocol (blue) immediately after the tibial nerve transection and 
repair. All the animals from the 3 treatment groups (n=18) were perfused one hour after 
completion of the AIH/normoxia treatment protocol on day 3 (72 hours post-repair). 
Tissues from the L3-L5 spinal cord region, L4 DRG and tibial nerve repair region were 
collected and processed for RAGs.		
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L3-L5 spinal cord region, L4 DRG and tibial nerve repair region were collected and 
processed for expression of RAGs.  
Mid-term timeline for FG retrograde tracing 
The effect of AIH or ES treatment on the regeneration of peripheral nerves was 
investigated using FG (Figure 3.1.3.2). In order to establish the total number of motor and 
sensory neurons contributing to the tibial nerve, a total of 12 animals had their right tibial 
nerve transected 5 mm distal from the sciatic trifurcation and the proximal stump soaked 
in 2% FG solution in saline for an hour (Day 0). Four of these animals were then 
immediately treated with the ES protocol. The remaining 8 animals were treated with 
either normoxia on day 2 and 3 (n=4) or AIH on day 2 and 3 (n=4). They were perfused 
on day 30 and tissues collected to observe dye distribution corresponding to the tibial 
nerve in motor neurons in the L3-L5 spinal cord region and in sensory neurons in the L4 
DRG.  
To establish the percentage of sensory and motor neurons that regenerated a 
significant distance from the tibial repair site 25 days post-repair, the tibial nerve was 
transected ~28 +/- 1 mm distal from the center of the silastic tube and soaked in 2% FG 
for an hour (See Figure 1.2.2 for tibial anatomical reference). A total of 21 animals 
underwent this procedure with their respective treatment protocols post-tibial nerve 
transection and repair: normoxia (n=6), AIH (n=6) and ES (n=9). On day 30, all of the 
animals were perfused and their tissues collected to observe dye distribution of the 
regenerated tibial nerve in motor neurons in the L3-L5 spinal cord region and in sensory 
neurons in the L4 DRG. 
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Figure 3.1.3.2 Experimental timeline - summary of methodology used to investigate 
the effect of AIH or ES on peripheral nerve regeneration. Top: A total of 10 animals 
underwent tibial nerve transection and repair with normoxia treatment (orange) on day 2 
and day 3. Of these 10 animals, 4 had the proximal stump of the tibial nerve at the repair 
site soaked in FG for an hour on day 0 and the remaining 6 had the tibial nerve 28 mm 
distal from the repair site transected and soaked in FG for an hour on day 25. Middle: A 
total of 10 animals underwent a tibial nerve transection and repair with AIH treatment 
(green) on day 2 and day 3. Of these 10 animals, 4 had the proximal stump of the tibial 
nerve at the repair site soaked in FG for an hour on day 0 and the remaining 6 had the 
tibial nerve 28 mm distal from the repair site transected and soaked in FG for an hour on 
day 25. Bottom: A total of 13 animals were treated with ES treatment protocol (blue) 
immediately after the tibial nerve transection and repair. Of these 13 animals, 4 had the 
proximal stump of the tibial nerve at the repair site soaked in FG for an hour on day 0 and 
the remaining 9 had the tibial nerve 28 mm distal from the repair site transected and 
soaked in FG for an hour on day 25. On day 30, all of the animals (n=33) were perfused 
and tissues collected to observe dye distribution in motor neurons in the L3-L5 spinal 
cord region and in sensory neurons in the L4 DRG. 																													
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Mid-term timeline for behavioural testing 
The effect of AIH or ES treatment on behaviours associated with peripheral nerve 
regeneration in the hind limb was investigated (Figure 3.1.3.3). A total of 14 animals  
underwent training/acclimatization to the walking footprint analysis apparatus, 
Hargreaves thermal hyperalgesia testing chambers, Von Frey mechanical hyperalgesia 
testing chambers and the ladder crossing apparatus for 14 days. Seven days prior to tibial 
nerve transection and repair (day 0), baseline values were determined for all of the 
behavioural tests: Walking footprint analysis (3 days x 3 prints per hind limb), 
Hargreaves (1 day x 5 trials per hind limb), Von Frey (1 day x 4 trials per hind limb) and 
ladder crossing (3 days x 10 crossings per day). On day 0, two animals did not undergo a 
tibial nerve transection and repair (naïve controls) and 12 animals did, followed by ES 
treatment (n=4), normoxia treatment (n=4) or AIH treatment (n=4). Starting on day 4, all 
of the animals were behaviour tested for a 21 day period: Walking footprint analysis (9 
days x 3 prints per hind limb), Hargreaves (5 days x 5 trials per hind limb), Von Frey (5 
days x 4 trials per hind limb) and ladder crossing (9 days x 10 crossings per day). On day 
30, the animals were perfused and tissues collected. 
Long-term timeline for behavioural testing 
With encouraging results obtained from the mid-term experimental timeline, the 
effect of AIH or ES treatment on behaviours associated with peripheral nerve 
regeneration in the hind limb was investigated over a 10 week recovery period (Figure 
3.1.3.4). A total of 18 animals underwent training/acclimatization as previously described 
for the mid-term timeline. For one week prior to tibial nerve transection and repair, the 
following baseline values were obtained: Walking footprint analysis (2 days x 3 prints	
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Figure 3.1.3.3 Experimental timeline - summary of methodology used to investigate 
the effect of AIH or ES on peripheral nerve regeneration-associated behaviours over 
25 days. In the mid-term experiment, a total of 14 animals underwent 
training/acclimatization to the walking footprint analysis apparatus, Hargreaves thermal 
hyperalgesia testing chambers, Von Frey mechanical hyperalgesia testing chambers and 
the ladder crossing apparatus for 14 days. Baseline values were established for all tests 
for 7 days prior to tibial nerve transection and repair (day 0): Walking footprint analysis 
(3 days x 3 prints per hind limb), Hargreaves (1 day x 5 trials per hind limb), Von Frey (1 
day x 4 trials per hind limb) and Ladder crossing (3 days x 10 crossings per day). Twelve 
animals underwent a tibial nerve transection and repair at day 0 and two animals 
remained uninjured (controls). Top: Four out of the 12 animals underwent normoxia 
treatment (orange) on day 2 and 3 following the tibial nerve transection and repair on day 
0. Middle: Four out of the 12 animals underwent AIH treatment (green) on day 2 and 3 
following the tibial nerve transection and repair on day 0. Bottom: Four out of the 12 
animals underwent ES treatment (blue) for an hour immediately after the tibial nerve 
transection and repair on day 0. Four days after tibial nerve repair, all of the animals 
underwent behavioural testing throughout a 21 period: Walking footprint analysis (9 days 
x 3 prints per hind limb), Hargreaves (5 days x 5 trials per hind limb), Von Frey (5 days x 
4 trials per hind limb) and Ladder crossing (9 days x 10 crossings per day). On day 30, 
the animals were perfused and tissues collected.  																										
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Figure 3.1.3.4 Experimental timeline - summary of methodology used to investigate 
the effect of AIH or ES on peripheral nerve regeneration-associated behaviours over 
10 weeks. In the long-term experiment, a total of 18 animals underwent 
training/acclimatization of the walking footprint analysis apparatus, Hargreaves 
thermalhyperalgesia testing chambers, Von Frey mechanical hyperalgesia testing 
chambers and the ladder crossing apparatus for 14 days. Baseline values were established 
for all tests for 7 days prior to tibial nerve repair: Walking footprint analysis (2 days x 3 
prints per hind limb), Hargreaves (1 day x 5 trials per hind limb), Von Frey (1 day x 4 
trials per hind limb) and Ladder crossing (2 days x 10 crossings per day). Fourteen 
animals underwent a tibial nerve transection and repair at day 0 and 4 animals remained 
uninjured (controls). Top: Five out of the 14 animals underwent normoxia treatment 
(orange) on day 2 and 3 following the tibial nerve transection and repair on day 0. 
Middle: Five out of the 14 animals underwent AIH treatment (green) on day 2 and 3 
following the tibial nerve transection and repair on day 0. Bottom: Four out of the 14 
animals underwent ES treatment (blue) for an hour immediately after the tibial nerve 
transection and repair on day 0. Four days after tibial nerve repair, all of the animals 
underwent behavioural testing for 66 days: Walking footprint analysis (2x per week x 3 
prints per hind limb), Hargreaves (1x per week x 5 trials per hind limb), Von Frey (1x per 
week x 4 trials per hind limb) and ladder crossing (2x per week x 10 crossings per day). 
On day 70, the animals were perfused and tissues collected. 
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per hind limb), Hargreaves (1 day x 5 trials per hind limb), Von Frey (1 day x 4 trials per 
hind limb) and ladder crossing (2 days x 10 crossings per day). On day 0, four animals 
did not undergo a tibial nerve transection and repair (controls) and 14 animals did	
followed by ES treatment (n=4), normoxia treatment (n=5) or AIH treatment (n=5). 
Starting on day 4, all of the animals underwent behavioural testing for 66 days: Walking 
footprint analysis (2x per week x 3 prints per hind limb), Hargreaves (1x per week x 5 
trials per hind limb), Von Frey (1x per week x 4 trials per hind limb) and ladder crossing 
(2x per week x 10 crossings per day). On day 70, the animals were perfused and tissues 
collected. 
 
3.1.4 Fluorogold® nerve labeling 
For the mid-term study, to identify the total number of sensory and motor neurons 
that contribute to the tibial nerve, the proximal end of the nerve, during the tibial nerve 
transection and repair procedure, was submerged in 4 µl of a 2% FG solution carefully 
pipetted into a Vaseline lined metal spatula for one hour. The tibial nerve was rinsed with 
sterile saline and was then repaired as described above using 10-0 silk suture and a 4 mm 
long section of Silastic® tubing. The muscle and skin were then sutured to close the 
wound as previously described.  
In order to determine the number of sensory and motor neurons that regenerated, 
the tibial nerve was exposed above the level of the ankle 25 days after the tibial nerve 
transection and repair with the same anesthetic and analgesic conditions as the original 
tibial nerve transection and repair procedure. The membrane between the soleus and 
gastrocnemius muscles was gently spread apart with blunt tip scissors to allow better 
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exposure. The tibial nerve was cut 28 mm +/- 1mm distal from the original repair site 
with Vanna micro-scissors (approximately 10 mm proximal from the footpad). Two µls 
of a 2% FG solution were carefully pipetted into a 4 mm section of silastic tubing that 
had one end sealed with medical grade silicone glue. The proximal end of the transected 
tibial nerve was then submerged in the solution in the tube for an hour. It was rinsed with 
sterile saline and the muscle and skin were then sutured to close the wound. The rats were 
killed 5 days after the FG application. In addition to the standard tissues collected, a 3 
mm section of the tibial nerve from both hind limbs located 20 mm distal from the 
original repair site was dissected and processed for Epon embedding as below. 
 
3.1.5 Animal perfusion and tissue preparation 
The rats were deeply anesthetized with an overdose of pentobarbital and perfused 
transcardially with 0.1 M PBS, pH 7.4, followed by 4% paraformaldehyde in 0.1 M PBS. 
The sciatic nerves, tibial nerves, spinal cord, bilateral L3, L4 and L5 DRG were carefully 
removed and post-fixed for 1-1.5h in 4% paraformaldehyde, then cryoprotected in 10% 
sucrose followed by 20 % sucrose overnight at 4°C. Initial studies of the DRG involved 
identifying the dorsal side of each ganglia with 10-0 suture prior to excision during 
dissection as well as leaving additional dorsal root attached to each to allow for consistent 
orientation when embedding for sectioning (Figure 3.1.3.5). It allowed for a better 
understanding of the location of the sensory neuron cell bodies associated with the tibial 
nerve. 
Experimental and control ganglia, nerves or spinal cord were frozen with OCT 
compound (Tissue Tek; Miles Laboratories, Elkhart, IN) in a cryomold (Tissue Tek,  
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Figure 3.1.3.5 Dissection of DRG and spinal cord. Initial studies of the DRG and 
lumbar spinal cord involved identifying the dorsal side of each ganglia including L2-L6 
with 10-0 suture prior to excision during dissection as well as leaving additional dorsal 
root attached to each to allow for consistent orientation when embedding for sectioning. 
Tissue collected for future studies included the region of the spinal cord receiving tibial 
nerve inputs from L3-L5 sensory neuron afferents, the L4 DRG containing the majority 
of the tibial nerve sensory neuron cell bodies, the tibial nerve repair site and a 3 mm 
region of nerve taken 20 mm distal to the tibial nerve repair site.  
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Miles Laboratories) as to ensure parallel processing. The L3, L4 and L5 ganglia were cut 
transversally and the tibial nerves and spinal cords were cut either longitudinally or 
transversally on a cryostat (Micron, Zeiss, Canada) into 8 or 10 µm sections and thaw  
mounted on Superfrost Plus slides (Fisher Scientific) for immunohistochemistry and 
Probe-On+ slides (Fisher Scientific) for in situ hybridization processing. 
 
3.2 Immunohistochemistry 
3.2.1 Visualization of protein expression with antibodies 
Slides were blocked with SeaBlock (Calbiochem) for an hour and subsequently 
treated with the following primary antibodies: mouse anti-ATF3 (Abcam, 1:500), rabbit 
anti-ATF3 (Santa Cruz, 1:1000), chicken anti-BDNF (R&D Systems, 1:100), mouse anti-
tubulin βIII isoform (Millipore, 1:100), rabbit anti-βIII tubulin (Millipore, 1:1000), 
mouse anti-GAP43 (Schreyer Lab, 1:1000), rabbit anti-HIF-1α (Genetex, 1:200) and 
rabbit anti-SCG10 (also known as phosphoprotein stathmin, MIM 151442, Novus 
Biologicals, 1:5000) in a solution comprised of 10% SeaBlock in 0.3% Triton X-100 in 
0.1 M PBS overnight. The next day, slides were washed in 0.1 M PBS and 
antigen/antibody complexes were visualized with donkey anti-mouse alexa 488 (1:1000), 
donkey anti-mouse dylight 594 (1:2000), goat anti-rabbit dylight 488 (1:1000), donkey 
anti-rabbit Cy3 (1:2000) or donkey anti-chicken Cy3 (1:1000) (all Jackson Laboratories). 
The slides were then washed three times in 0.1M PBS and coverslipped using Prolong 
Gold anti-fade reagent with or without DAPI (Invitrogen – Molecular Probes, Carlsbad, 
CA) or using a 50% glycerol/50% 0.1M PBS solution. Control sections were processed in 
the same manner while omitting the primary antibody. All slides were stored at -20°C in 
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lightproof bags. 
 
3.2.2 In situ hybridization  
 Hybridization was performed according to published procedures (Dagerlind et al., 
1992) with a custom 48 mer oligonucleotide probe complementary to and selective for 
HIF mRNA with the following synthesized sequence (Univ. of Calgary DNA services, 
AB): CAGTTTCCGTGTCATCGCTGCCGAAGTCCAGTGATATGATCGTGTCCC 
The probes were labeled at the 3’-end with α-[35S]dATP (New England Nuclear, Boston, 
MA) using terminal deoxynucleotidyl-transferase (Amersham Pharmacia Biotech, 
Piscataway, NJ) in a buffer containing 10 mM CoCl2, 1 mM dithiothreitol, 300 mM Tris 
base and 1.4 M C2H6AsKO2. The probes were purified using Bio-Spin Disposable 
Chromatograph Columns (Bio-Rad Laboratories, Hercules, CA) with 200 mg of 
NENSORB PREP Nucleic Acid Purification Resin. Dithiothreitol was added to obtain a 
final concentration of 10 nM. The sections were hybridized at 43°C for 14-18h in a buffer 
containing 107 cpm/ml of probe. After hybridization, the slides were washed, dehydrated, 
processed for radioautography as per Karchewski et al. (2002) and exposed for 7 days 
before developing in D-19 (Kodak, Rochester, NY). Slides were stained with 0.25% 
toluidine to visualize cell structure.  
 
3.2.3 Visualization of Fluorogold® distribution 
 L4 DRGs (left and right) and ventral motor side of the L3 to L5 spinal cord were 
serially cut into 10 µm sections. Every second slide was used for counts. The DRGs were 
photographed using Northern Eclipse® (Empix Imaging Inc.) and the FG labeled sensory 
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neurons in the DRGs counted using Fiji® (Image J, Version 2.0.0, Open Source). The FG 
labeled motor neurons in the spinal cords were manually counted. The transverse nerve 
sections were photographed using Northern Eclipse® (Empix Imaging Inc.) to ensure that 
FG dye uptake was not systemic. 
 
3.2.4 Visualization of axonal regeneration 
 The three mm sections of tibial nerves dissected 20 mm distal from the original 
repair site were processed for Epon resin embedding (Western College of Veterinary 
Medicine at the University of Saskatchewan). One micron transverse semi-thin sections 
were cut from each animal of both left and right tibial nerves and counterstained with 
Toluidine Blue to visualize the regenerating axons in each nerve section. Images were 
taken of the highest quality section from each nerve, absent tissue folds and with even 
staining, with a Zeiss Axio Imager 1 microscope system with Northern Eclipse® (Empix 
Imaging Inc.) software using a 40X objective and the images reassembled using Adobe® 
Photoshop® CS3 (Adobe Systems Inc., USA). The images were blinded and the thinly 
myelinated and medium myelinated as well as the degenerating axon profiles were 
individually identified and counted using Fiji® (Image J, Version 2.0.0, Open Source). 
 
3.2.5 Quantification of immunohistochemical signal 
All slides were initially analyzed qualitatively and relative changes in 
immunohistochemistry labeling intensity between experimental groups were noted within 
each slide to omit discrepancies in background labeling intensity. Slides were selected for 
experimental analysis such that they had similar numbers of neurons or tissue in the 
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sections representing each experimental group. Images were taken under identical 
conditions for each section on individual slides on a Zeiss Axio Imager 1 microscope 
system with Northern Eclipse® (Empix Imaging Inc.) software using a 40X objective for 
quantitative sensory neuron analysis and a 20x objective for quantitative motor neuron 
and tibial nerve analysis. After photographing all sections on a slide, images of each 
DRG or spinal cord were taken with a 10X objective to create photomontages of each 
section to be analyzed which were then assembled using Adobe® Photoshop® CS3 
(Adobe Systems Inc., USA) to ensure that all neurons with a visible nucleus were only 
traced once. For neuronal profiles, the circumference of the neuron was traced as well as 
the nucleus using tablet tracing software (Bamboo, Wacom Ltd, Japan) with inputs into 
Northern Eclipse® (Empix Imaging Inc.) which computed the diameter of each 
individual neuron and its respective average cytoplasmic and nuclear 
immunohistochemical labeling intensity.  
 
3.2.6 Statistical analysis 
Each data point for individual neurons or nerves analyzed was normalized to the 
mean immunohistochemical labeling intensity from the normoxia treatment group using 
Microsoft Excel software (Microsoft Corp., USA). In the case of cells being double-
labeled as ATF3-(uninjured) or ATF3+(injured), the individual neurons were normalized 
to the mean immunohistochemical labeling intensity of the ATF3- cells from the 
normoxia treatment group. A Kruskall-Wallis non-parametric ANOVA (Prizm 4.0, Graph 
Pad Software, San Diego, CA) was used to compare the cytoplasmic or nuclear 
immunohistochemistry labeling intensity as well as the number of cell bodies and axons 
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between treatment groups. Statistical significance was accepted at p <0.05 level. 
Supplemental statistical and graphical manipulations were performed with Prizm 4.0 
(Graph Pad Software, San Diego, CA) and Microsoft Excel (Microsoft Corp., USA).  
 
3.3 Behavioural testing 
Milk chocolate Ensure® was heated with gelatin to create 5 mm by 5 mm by 5 
mm cubes as food rewards for both the mid-term and long-term behavioural testing 
sessions. 
 
3.3.1 Thermal hyperalgesia test 
The Hargreaves plantar test apparatus consists of three clear plexiglass boxes (22 
cm long by 17 cm wide by 14 cm high each) whose clear plexiglass floor sits above a 
moveable infrared source connected to a controller that counts reaction time (Figure 
3.3.1). The infrared source is placed under the center of both hind limb footpads and the 
thermal threshold of foot withdrawal is then displayed on the controller with a 5 minute 
rest period in between each hind limb recording. Five recordings were done per hind limb 
per testing session with two baselines and five testing sessions spread out within the three 
weeks post-surgery. For each of the three experimental groups, a repeated measures 
ANOVA was performed (Prizm 4.0, Graph Pad Software, San Diego, CA) with treatment 
and time as variables.  
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Figure 3.3.1 Thermal hyperalgesia testing apparatus. The Hargreaves testing 
apparatus consisted of three plexiglass chambers (22 cm long by 17 cm wide by 14 cm 
high each) on a raised plexiglass floor. An infrared heat source was placed in the center 
of the hind limb footpad producing heat with a timer running simultaneously. The 
withdrawal time of each hind limb from the heat source was recorded five times per 
testing session with a 5 minute rest period between each hind limb recording. 
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3.3.2 Mechanical hyperalgesia test 
The Von Frey test apparatus consists of three clear plexiglass boxes (22 cm long 
by 17 cm wide by 14 cm high each) with the floor having 1.5 mm diameter holes that are  
evenly spaced (Figure 3.3.2). An electric von Frey filament is applied to the center of the 
hind limb footpads to establish mechanical force threshold (in grams) of foot withdrawal, 
which is then displayed on a controller. The von Frey filaments were applied in order of 
increasing stiffness for each rat to establish the smallest filament to evoke a withdrawal 
response. It was determined that the #14 28 gram super tip was optimal in producing a 
consistent withdrawal response without reaching maximal flex in the filament. The 
withdrawal pressure per hind limb was recorded four times per testing session with 5 
minutes rest period in between each hind limb recording. Two baselines and five testing 
sessions were recorded spread out within the three weeks post-surgery. For each of the 
three experimental groups, a repeated measures ANOVA was performed (Prizm 4.0, 
Graph Pad Software, San Diego, CA) with treatment and time as variables.  
 
3.3.3 Ladder crossing test 
The ladder is 80 cm long with 20 cm opaque plexiglass platforms at both ends 
with clear plexiglass walls (Figure 3.3.3). The ladder consists of 2 mm diameter wire 
rungs that are spaced by 1 cm. The ladder sits above an angled mirror so that both the 
side and bottom aspects of the ladder can be video recorded. Rats were trained to cross 
the ladder to the opposite platform by having a food reward present when animals 
traversed. The ladder apparatus was wiped with 70% alcohol between sessions. Over ten 
ladder crossings were recorded with a video camera and video analysis was performed on  
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Figure 3.3.2 Mechanical hyperalgesia testing apparatus. The Von Frey testing 
apparatus consisted of three plexiglass chambers (22 cm long by 17 cm wide by 14 cm 
high each) on a raised metal floor with evenly spaced 1.5 mm holes (see grid pattern 
viewed from above on Bottom Figure). Through the holes from below, the tip of an 
electric von Frey filament (red arrow) was applied to both hind limbs to establish 
mechanical force threshold (in grams) of foot withdrawal, which is then displayed on a 
controller (left apparatus on Top Figure). The withdrawal pressure per hind limb was 
recorded four times per testing session with a 5 minute rest period in between each hind 
limb recording. 
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Figure 3.3.3 Ladder crossing testing apparatus. The ladder crossing testing apparatus 
was custom-made out of clear plexiglass and measured 80 cm long with 20 cm opaque 
platform at each end. Two millimeters metal pegs are evenly spaced by 1 cm along the 
track. It sits above an angled mirror so that video recordings can show the animal’s 
positioning as well as their hind limb and toe placements on/between the pegs. Ten ladder 
crossings were recorded per testing session. 
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blinded videos on ten crossings with no breaks or stops. Each paw was scored at two 
occasions per crossing for positioning on the rings whether it was normal (grasps with 
both the digits and the plantar surface of the hind paw), mostly digits (uses digits only to 
contact the rung), wrist (no grasping with the digits, only the plantar surface is against the 
rung), a corrected step (the paw is initially placed on a rung and is immediately lifted and 
placed on another rung) or a slip (when the hind paw slips through the rungs). When a 
slip occurred, no quantification was done until the rat had done a full stride to prevent 
any rebalancing having an impact on subsequent hind limb placement. Three testing 
sessions were done per week for a baseline then for three weeks or 10 weeks post-
surgery. For each of the three experimental groups, a repeated measures ANOVA was 
performed (Prizm 4.0, Graph Pad Software, San Diego, CA) on each of the scoring 
parameters (normal, mostly digits, wrist, corrected step or slip) with treatment and time 
as variables.  
 
3.3.4 Walking footprint analysis test 
The walking track is 50 cm long, 8 cm wide and 12 cm high with clear plexiglass 
walls set within a clear plastic basin (Figure 3.3.4). The rats’ hind feet were covered with 
non-toxic water based black ink (Trodat®) using cotton balls for application, allowed to 
walk across a strip of white paper that was taped to the floor of the track then washed 
with dampened cotton balls. A food reward was placed at the end of the track to 
encourage a continuous set of prints without any stopping or swaying. Three (mid-term 
experiment) or two (long-term experiment) testing sessions were done for a week of 
baseline measurements then repeated weekly for three (mid-term experiment) or 10  
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Figure 3.3.4 Walking footprint analysis testing apparatus. The footprint apparatus 
was custom-made out of clear plexiglass and measured 50 cm long, 8 cm wide and 12 
cm high, placed within a clear plastic basin. The animal’s hind feet were dabbed with 
black ink and they were encouraged to walk within the testing track with treats. Three 
paper strips of prints were collected per testing session. 
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(long-term experiment) weeks post-surgery. Three paper strips of prints were collected 
per testing session with the three prints that were the most defined with the least smearing 
from each hind limb were kept for analysis. Placement of each hind paw based on the ink  
prints was analyzed as follows (Bain, Mackinnon, and Hunter 1989): 
a. Measurement of average print length on both the experimental (EPL) and normal 
side (NPL). 
b. Measurement of toe spread between the first and fifth digits on both sides (ETS 
and NTS). 
c. Measurement of the distance between the second and fourth toes on both sides 
(EIT and NIT). 
d. The formula to calculate the tibial nerve function index (TFI) is:  
TFI = -38.8 (EPL-NPL)/NPL + 109.5(ETS-NTS)/NTS + 13.3(EIT-NIT)/NIT – 
8.8 
e. For each of the three experimental groups, a repeated measures ANOVA was 
performed (Prizm 4.0, Graph Pad Software, San Diego, CA) with treatment and 
time as variables.  
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4. Results 
 
4.0 Analysis of plasticity-associated gene expression in lumbar sensory neurons from 
AIH treated spinal cord injured rats reveals potential of AIH to impact PNS 
The preliminary studies that established the hypothesis in this thesis were initially 
done on PNS tissue from Lewis rats that had undergone a cervical partial spinal cord 
injury with or without one or 7 days AIH treatment one month following injury. Sensory 
neurons remote from the injury site were examined to see if AIH had an impact on 
RAGs. Thus, lumbar DRG were processed for immunofluorescence to detect AIH-
associated changes in GAP43 and BDNF expression.  Expression of both BDNF and 
GAP43 in sensory neurons was elevated in the animals that underwent cervical spinal 
cord injury coupled with 1 day (n=2) or 7 days (n=2) AIH treatment relative to those 
injured animals receiving normoxia treatment (n=2; Figure 4.0.1). Surprisingly, one day 
of AIH treatment was sufficient to induce these robust changes in RAGs in sensory 
neurons, with 7 days of AIH treatment not appearing to increase protein levels much 
beyond that observed with 1 day. Another member of our lab, Dr. Atiq Hassan, also 
observed similar alterations in gene expression in the lumbar motor neurons (Hassan 
2015).  The DRG RAG and AIH immunofluorescence were confirmed in repeat 
experiments and another marker induced by AIH and very recently linked to peripheral 
nerve repair (Cho et al. 2015), HIF-1α was examined using in situ hybridization (Figure 
4.0.2). An increase in hybridization signal was observed over L5 DRG sections in rats 
that underwent AIH treatment relative to normoxia controls, that was most robust in 
spinal cord injured rats receiving 1 day AIH versus 7 days AIH treatment.  Νο further in 
situ hybridization experiments were performed due to an ongoing inability to buy isotope 
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Figure 4.0.1 Preliminary data showing AIH treatment elevates expression of 
plasticity-associated genes in sensory neurons. Fluorescence photomicrographs of 10 
µm lumbar DRG sections from Lewis rats processed for immunohistochemistry to detect 
GAP43 protein expression (top) and BDNF protein expression (bottom) in response to 
normoxia (left), 1 day AIH (middle) or 7 days AIH treatment (right). Note: AIH 
treatment for 1 day (n=2) or 7 days (n=2) one month following cervical spinal cord injury 
leads to an increase in neuronal GAP43 protein and BDNF protein expression compared 
to normoxia treated controls (n=2). Scale bar = 30 µm  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.0.2 Preliminary data showing AIH treatment elevates expression of HIF-1! 
in sensory neurons. Dark field photomicrographs of 8 µm lumbar DRG sections 
processed for in situ hybridization depict levels of HIF-1 mRNA treated with normoxia 
(left), 1 day of AIH (middle) and 7 days of AIH (right). Note: AIH treatment for 1 day 
(n=2) or 7 days (n=2) one month following cervical spinal cord injury leads to a 
widespread increase in HIF-1 mRNA throughout the DRG relative to normoxia control 
(n=2). Unfortunately, due to supply unavailability of radioactive isotope that would 
reliability label any of our oligonucleotide probes, no in situ hybridizations were done to 
substantiate these results. Scale bar = 500 µm 
HIF 
 
-1! 
Normoxia 1day AIH 7day AIH 
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that reliably labels the oligonucleotide probes. 
Collectively, these exciting preliminary insights prompted further investigations 
and the development of my thesis project examining whether the heightened RAG 
expression induced by AIH might occur in injured and repaired sensory and motor 
neurons and prove beneficial to repair in a less invasive manner, but with results akin to 
that which we have observed in response to one hour brief electrical nerve stimulation 
(ES; 20Hz) at the time of nerve repair (Al-Majed et al. 2000, Geremia et al. 2007, 
reviewed in Gordon and Borschel 2016). 
We chose to create an AIH tibial nerve repair model, where the tibial branch of 
the sciatic nerve was transected just distal to the sciatic nerve trifurcation and repaired in 
the same manner as that used for the femoral nerve in Geremia et al. (2007), followed by 
either immediate one hour ES of the sciatic nerve proximal or AIH treatment for either 
one or two consecutive days beginning one day post-injury and repair. The initial 
attempts to examine the potential of AIH treatment to improve peripheral nerve repair 
were conducted in the Wistar strain of rat utilized in our previous ES studies.  However, 
unlike the Lewis rats, no significant increases in GAP43 immunofluorescence was 
observed in DRG neurons at 3 days post-injury and repair with either one day or two days 
of AIH treatment in these rats. However, the expected increases were observed in the ES 
group as previously published (Geremia et al. 2007) (Figure 4.0.3). Thus, all future 
investigations were conducted using the Lewis rat strain.  
Due to the tibial nerve repair model being new to our research group, FG 
retrograde labeling of the tibial nerve was also done to examine the distribution of its 
sensory and motor neuron cell bodies in the Lewis rat.  The L3, L4 and L5 DRG as well  
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Figure 4.0.3 AIH treatments for 1 day or 2 days does not increase GAP43 protein 
expression in lumbar sensory neurons 3 days post nerve repair in Wistar rats. 
Fluorescence photomicrographs of L4 DRG 10 µm sections processed for dual 
immunofluorescence to detect cytoplasmic GAP43 (green) protein levels in injured 
activated transcription factor-3 (ATF3; blue) positive (ATF3+ve) or uninjured ATF3 
negative (ATF3-ve) sensory neurons from rats that underwent tibial nerve repair followed 
by 1 day normoxia (top left), 1 day AIH (top middle), 2 day normoxia (bottom left), 2 
day AIH (bottom middle) or 1 hour ES (bottom right) treatment. Note: ES treatment 
results in increased expression of GAP43 in the cytoplasm of sensory neurons, most 
notably in the smaller cells with a diameter of 12-30 µm, compared to normoxia controls. 
No changes in expression levels of GAP43 were observed with 1 or 2 days of AIH 
treatment, contrary to our preliminary results in Lewis rats and our hypothesis. GAP43 is 
also expressed in the sympathetic axons distributed throughout the DRG, appearing as 
fibers between the sensory neurons, however no qualitative changes were observed in 
their GAP43 expression levels with the various treatments. Scale bar = 30 µm. 
 
ATF3 
GAP43 
1 day Norm 1 day AIH 
2 day Norm 2 day AIH ES 
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as the L3 to L6 spinal cord were collected 5 days after dye application. The distribution 
of the tibial nerve to the DRGs has been reported within the following approximate 
ranges for the Sprague-Dawley and Sabra/Wistar strains of rats: L3 0-1%, L4 40-68%, L5 
30-60% and L6 0-5% (Swett et al. 1991, Devor et al. 1985, Asato et al. 2000). In 
addition, a thorough literature search at the time did not yield any information as to 
whether any of the nerves are segregated/organized within the DRG, thus prior to 
dissection, by identifying the dorsal side of the DRG with suture and leaving the attached 
dorsal root longer than the attached spinal nerve, it allowed for topographical analysis of 
the DRGs (Figure 3.1.3.5). 
The greatest number of FG-labeled sensory neurons in our Lewis rats was in the 
L4 DRG with over 50% of its population, whereas the L5 DRG, being smaller in size and 
in number of sensory neuron cell bodies than the L4, had less than 40% of its population 
FG-labeled (data not shown). Swett et al. (1991) reported that the L4 DRG contains more 
than twice the number of tibial neurons than the L5 in the Sprague-Dawley strain. This 
determined that the L4 was the primary DRG for all of our investigations. In addition, 
topographical orientation of the L4 DRG revealed that neurons with axons in the tibial 
branch of the sciatic nerve distribute closer to the dorsal root side of the L4 DRG and are 
predominantly on the ventral side with very few present on the dorsal side (data not 
shown). Our usual technique that involves laying the DRG on their ‘flat side’ in the 
molds for cryo-processing, has the dorsal sides of the DRGs sectioned first and thus 
many initial studies where only 10-20 sections were cut, missed the actual tibial neurons. 
Thus, our embedding and sectioning protocol was also modified. 
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4.1 Impact of AIH or ES versus normoxia treatment on early expression of RAG 
proteins in regenerating tibial nerve and associated motor and sensory neurons 
It should be noted that for all markers examined, similar qualitative trends were 
observed between experimental groups for all animals in each experimental group. In 
regards to the sensory neurons, located in the L4 DRGs, three out of six groupings of 
different experimental animals were selected for detailed quantitative analysis. This 
selection was based on having a similar number of sensory neurons in each of the three 
DRG  sections on the slide such that a minimum of 80 sensory neurons with ATF3+ve 
(positive) nuclei identifying those neurons contributing axons to the injured tibial nerve 
branch and another 80 with ATF3-ve (negative) nuclei identifying L4 DRG neurons not 
contributing axons to the injured tibial nerve could be traced and quantified for each 
animal. This yielded separate immunofluorescence signal intensity values for the nuclei 
and the cytoplasm for the marker examined.   
In the motor neurons, located in the L4 region of the spinal cord, the protein 
expression levels were analyzed qualitatively in six animals and three of these animals 
that had the highest number of both ATF3-ve and ATF3+ve labeled nuclei in the processed 
sections were quantitatively analyzed. A minimum of 50 motor neurons that had ATF3+ve 
nuclei and another 50 motor neurons with ATF3-ve nuclei were traced per animal using 
the same image analysis program as for the sensory neurons. Each neuronal population 
was normalized to the mean immunofluorescence signal intensity of the uninjured ATF3-
ve nuclei cells from the normoxia treatment group on the same immunohistochemical 
slide, containing a section from each treatment group .  Further, all digital images were 
captured under identical conditions for ganglia or spinal cord sections from all 
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experimental groups mounted on the same slide, then images were blinded prior to 
quantification. These approaches to quantification were consistent with those employed 
in our previous ES studies (Geremia et al. 2007, Verge 2004, Pettersson et al. 2014). 
 
4.1.1 Neuronal GAP43 expression  
In sensory neurons, both AIH and ES treatments resulted in significant increases 
in cytoplasmic GAP43 protein levels in their cell bodies located in L4 DRG at 3 days 
post-repair relative to repair with normoxia treatment (Figure 4.1.1.1, Table 4.1.1.1).  The 
graph and table summarize these findings which reveal that while small (9% AIH; 7% 
ES) but significant increases were observed in the uninjured neurons, there was a much 
larger response (62% AIH; 67% ES; 37% Norm) in the injured and repaired neurons 
contributing to the tibial nerve relative to the uninjured ATF3-ve neurons in the normoxia 
treatment group.  The increased GAP43 expression in injured neurons in response to AIH 
or ES was most notable in the small size neurons, previously shown to already express 
GAP43 at moderate levels when uninjured (Verge et al. 1990, Schreyer and Skene 1991). 
In addition to the observed neuronal changes, it was noted that elevated GAP43 
expression was evident in the perineuronal cells in the AIH treated animals relative to 
normoxia treatment (Figure 4.1.1.1). 
In motor neurons at the level of the L4 spinal cord, it was observed that AIH as 
well as ES treatment increased GAP43 protein levels at 3 days post-repair in their cell 
bodies as compared to normoxia treatment and surprisingly, this effect was observed 
regardless of whether the motor neurons were injured (ATF3+ve) or uninjured (ATF3-ve) 
(Figure 4.1.1.2, Table 4.1.1.2). The graph and table summarize these findings depicting a	
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Figure 4.1.1.1 AIH or ES treatment results in increased GAP43 protein expression 
in sensory neurons 3 days post nerve repair. Top: Fluorescence photomicrographs of 
L4 DRG 10 µm sections processed for dual immunofluorescence to detect cytoplasmic 
GAP43 (green) protein levels in injured activated transcription factor-3 (ATF3; blue) 
positive (ATF3+ve) or uninjured ATF3 negative (ATF3-ve) sensory neurons from rats that 
underwent tibial nerve repair followed by 2 day normoxia, AIH or 1 hour ES treatment. 
Note: AIH treatment, unlike in the Wistar strain of rat, results in increased expression of 
GAP43 compared to normoxia controls. Increased labeling is also seen in the 
perineuronal cells (white arrow). ES treatment also had higher expression compared to 
normoxia controls. Higher levels of GAP43 expression are seen primarily in the smaller 
population of sensory neurons. Scale bar = 20 µm. Bottom: Graph depicts quantification 
of relative changes in the cytoplasmic immunofluorescence levels for GAP43 in neurons 
with or without ATF3+ve nuclei in L4 DRG from rats treated with either AIH or ES and 
compared to normoxia controls post-tibial nerve repair. The data is normalized to the 
mean of the sensory neurons from the normoxia treatment group without ATF3+ve nuclei 
(i.e. uninjured). Asterisks indicate significant differences between experimental groups 
(Kruskal-Wallis test with Dunn’s Multiple Comparison test; * p<0.05, ** p<0.01, *** 
p<0.001; N=555-690 total neurons analyzed from 3 animals per treatment group).  
ATF3 
GAP43 
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GAP43 in Sensory Neurons 
Treatment Normoxia AIH ES 
Mean immunofluorescence 
signal intensity ATF3+ve cells 
1.37 +/- 
0.0282 s.e.m. 
1.62 +/- 
0.0398 s.e.m. 
1.65 +/- 
0.0453 s.e.m. 
# of cells 259 304 256 
# of animals 3 3 3 
Significance (p) - p<0.05 p<0.01 
Mean immunofluorescence 
signal intensity ATF3-ve cells 
1.00 +/- 
0.0070 s.e.m. 
1.09 +/- 
0.0114 s.e.m. 
1.07 +/- 
0.0133 s.e.m. 
# of cells 337 385 298 
# of animals 3 3 3 
Significance (p) - p<0.001 p<0.01 
 
Table 4.1.1.1 The mean cytoplasmic immunofluorescence signal intensity of GAP43 in 
uninjured sensory neurons (ATF3-ve nuclei) with AIH treatment or ES treatment as 
normalized to normoxia treatment increased significantly. In addition, in the injured 
ATF3+ve nuclei population of these cells, the cytoplasmic mean labeling intensity with 
AIH treatment or ES treatment compared to normoxia treatment also increased 
significantly. 
 
GAP43 in Motor Neurons 
Treatment Normoxia AIH ES 
Mean immunofluorescence 
signal intensity ATF3+ve cells 
1.09 +/- 
0.0153 s.e.m. 
1.17 +/- 
0.0087 s.e.m. 
1.27 +/- 
0.0106 s.e.m. 
# of cells 159 154 196 
# of animals 3 3 3 
Significance (p) - p<0.001 p<0.001 
Mean immunofluorescence 
signal intensity ATF3-ve cells 
1.00 +/- 
0.0120 s.e.m. 
1.10 +/- 
0.0078 s.e.m. 
1.13 +/- 
0.0109 s.e.m. 
# of cells 156 194 191 
# of animals 3 3 3 
Significance (p) - p<0.001 p<0.001 
 
Table 4.1.1.2 The cytoplasmic mean labelling intensity in uninjured motor neurons with 
ATF3-ve nuclei with AIH treatment or ES treatment as normalized to normoxia treatment 
increased significantly. The same relationship was observed in the injured ATF3+ve nuclei 
population of these cells; the cytoplasmic mean labeling intensity with AIH treatment or 
ES treatment compared to normoxia treatment increased significantly.  
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Figure 4.1.1.2 AIH or ES treatment results in increased GAP43 protein expression 
in motor neurons 3 days post nerve repair. Top: Fluorescence photomicrographs of 10 
µm lumbar spinal cord sections processed for dual immunofluorescence to detect 
cytoplasmic GAP43 (green) protein levels in injured ATF3 (blue) positive (ATF3+ve) or 
uninjured ATF3 negative (ATF3-ve) motor neurons from rats that underwent tibial nerve 
repair followed by 2 day normoxia, AIH or 1 hour ES treatment. Arrows identify 
representative motor neurons with (injured, full arrows) or without (uninjured, dashed 
arrows) ATF3+ve nuclei. Note: AIH and ES treatment results in increased expression of 
GAP43 in the cytoplasm of injured and uninjured motor neurons as well as the neuropil 
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*** 
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compared to normoxia controls. Additionally, ATF3 expression levels in ES treated 
injured motor neurons appears higher both in the cytoplasm and nucleus compared to 
AIH and normoxia treatment. Scale bar = 30 µm. Bottom: Graph depicts quantification of 
relative changes in the cytoplasmic immunofluorescence levels for GAP43 in motor 
neurons with or without ATF3+ve nuclei in spinal cord from rats treated with either AIH 
or ES and compared to normoxia controls post-tibial nerve repair. The data is normalized 
to the mean of the motor neurons from the normoxia treatment group without ATF3+ve 
nuclei (i.e. uninjured). Asterisks indicate significant differences between experimental 
groups (Kruskal-Wallis test with Dunn’s Multiple Comparison test; *p<0.05, ** p<0.01, 
*** p<0.001; N=315-387 total neurons analyzed from 3 animals per treatment group).  
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significant effect in both the injured (ATF+ve) (17% AIH; 27% ES; 9% Norm) and the 	
uninjured (ATF3-ve) (10% AIH; 13% ES) motor neuron populations relative to normoxia 
treatment. Beyond increased expression in the motor neuron cytoplasm there was an even 
larger rise in GAP43 protein levels in both the AIH and the ES treatment groups 
compared to the normoxia treatment group in the grey matter neuropil surrounding the 
quantified motor neurons (Figure 4.1.1.2). Additionally, ATF3 labeling was noted to be 
increased in the cytoplasm in both the sensory and motor neurons in the ES treatment 
group compared to the normoxia and AIH treatment groups (Figures 4.1.1.1 and 4.1.1.2).  
 
4.1.2 Neuronal BDNF expression 
In sensory neurons, it was observed that AIH treatment significantly increased 
cytoplasmic BDNF protein levels in the cell bodies in L4 DRG at 3 days post-repair 
(Figure 4.1.2.1, Table 4.1.2.1). The graph and table summarize these conclusions. The 
AIH treatment produced significant increases in BDNF expression in both the ATF3-ve 
and the ATF3+ve sensory neuron populations (5% and 21% respectively) compared to the 
normoxia treatment (0% and 9% respectively). Unlike GAP43 expression levels in the 
sensory neurons, the ES treatment did not significantly increase BDNF expression levels 
(Figures 4.1.1.1 and 4.1.2.1). More specifically, there was no significant effect on the 
ATF3-ve population (3%), however the ATF3+ve population was found to express 
significantly lower increases in levels of BDNF with ES treatment (17%) than the AIH 
treatment group (21%).  
It was observed that AIH or ES increased BDNF protein levels in the motor 
neurons in L4 spinal cord (Figure 4.1.2.2, Table 4.1.2.2). The values in the graph and  
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Figure 4.1.2.1 AIH treatment results in increased BDNF protein expression in 
sensory neurons 3 days post nerve repair. Top: Fluorescence photomicrographs of L4 
DRG 10 µm sections processed for dual immunofluorescence to detect cytoplasmic 
BDNF (green) protein levels in injured ATF3 (blue) positive (ATF3+) or uninjured ATF3 
negative (ATF3-) sensory neurons from rats that underwent a tibial nerve repair followed 
by 2 day normoxia, AIH or 1 hour ES treatment. Note: AIH and ES treatment results in 
increased expression of BDNF in the cytoplasm of sensory neurons compared to 
normoxia controls. BDNF is also expressed in the satellite glial cells which appear as 
semi-lunar structures wrapping the sensory neurons. Scale bar = 20 µm. Bottom: Graph 
depicts quantification of relative changes in the cytoplasmic immunofluorescence levels 
for BDNF in sensory neurons with or without ATF3 positive nuclei in L4 DRG from rats 
treated with either AIH or ES compared to normoxia controls post-tibial nerve repair. The 
data is normalized to the mean of the sensory neurons from the normoxia treatment group 
without ATF3 positive nuclei (i.e. uninjured). Asterisks indicate significant differences 
between experimental groups (Kruskal-Wallis test with Dunn’s Multiple Comparison 
test; * p<0.05, ** p<0.01, *** p<0.001; N = 532-555 total neurons analyzed from 3 
animals per treatment group). 
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BDNF in Sensory Neurons	
Treatment Normoxia AIH ES 
Mean immunofluorescence 
signal intensity ATF3+ve cells 
1.09 +/- 
0.0130 s.e.m. 
1.21 +/- 
0.0171 s.e.m. 
1.17 +/- 
0.0209 s.e.m. 
# of cells 277 264 282 
# of animals 3 3 3 
Significance (p) - p<0.001 p<0.05 
Mean immunofluorescence 
signal intensity ATF3-ve cells 
1.00 +/- 
0.0109 s.e.m. 
1.05 +/- 
0.0122 s.e.m. 
1.03 +/- 
0.0109 s.e.m. 
# of cells 266 268 273 
# of animals 3 3 3 
Significance (p) - p<0.05 p>0.05 
 
Table 4.1.2.1 The cytoplasmic mean labelling intensity in uninjured sensory neurons 
with ATF3-ve nuclei increased significantly with AIH treatment as normalized to 
normoxia treatment but did not increase significantly with ES treatment. In the injured 
ATF3+ve nuclei population of these cells, there was a significant impact of AIH treatment 
on BDNF expression as the cytoplasmic mean labeling intensity increased as compared to 
the ES treatment group and the normoxia treatment. 
 
BDNF in Motor Neurons 
Treatment Normoxia AIH ES 
Mean immunofluorescence 
signal intensity ATF3+ve cells 
1.04 +/- 
0.011 s.e.m. 
1.17 +/- 
0.0133 s.e.m. 
1.27 +/- 
0.0207 s.e.m. 
# of cells 160 173 204 
# of animals 3 3 3 
Significance (p) - p<0.001 p<0.001 
Mean immunofluorescence 
signal intensity ATF3-ve cells 
1.00 +/- 
0.0094 s.e.m. 
1.11 +/- 
0.0098 s.e.m. 
1.22 +/- 
0.0193 s.e.m. 
# of cells 180 176 206 
# of animals 3 3 3 
Significance (p) - p<0.001 p<0.001 
 
Table 4.1.2.2 The cytoplasmic mean labelling intensity in uninjured motor neurons with 
ATF3-ve nuclei with AIH treatment or ES treatment as normalized to normoxia treatment 
increased significantly. The same relationship was observed in the injured ATF3+ve nuclei 
population of these cells; the cytoplasmic mean labeling intensity with AIH treatment or 
ES treatment compared to normoxia treatment also increased significantly.  
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Figure 4.1.2.2 AIH or ES treatment results in increased BDNF protein expression in 
motor neurons 3 days post nerve repair. Top: Fluorescence photomicrographs of 10 
µm lumbar spinal cord sections processed for dual immunofluorescence to detect 
cytoplasmic BDNF (green) protein levels in injured ATF3 (blue) positive (ATF3+) or 
uninjured ATF3 negative (ATF3-) motor neurons from rats that underwent tibial nerve 
repair followed by 2 day normoxia, AIH or 1 hour ES treatment. Arrows identify 
representative motor neurons with (injured, full arrows) or without (uninjured, dashed 
arrows) ATF3 positive nuclei. Note: Note: AIH and ES treatment results in increased 
expression of BDNF in the cytoplasm of injured and uninjured motor neurons as well as 
ATF3 
BDNF 
Norm AIH ES 
ATF3 Norm AIH ES 
*** 
*** 
*** 
*** 
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the neuropil compared to normoxia controls. Additionally, as observed in the spinal cord 
sections processed for GAP43, these sections processed for BDNF show increased 
expression levels of ATF3 in ES treated injured motor neurons both in the cytoplasm and 
nucleus compared to AIH and normoxia treatment. Scale bar = 30 µm. Bottom: Graph 
depicts quantification of relative changes in the cytoplasmic labeling intensity of BDNF 
in neurons with or without ATF3 positive nuclei in spinal cord from rats treated with 
either AIH or ES compared to normoxia controls post-tibial nerve repair. The data is 
normalized to the mean of the motor neurons from the normoxia treatment group without 
ATF3 positive nuclei (i.e. uninjured). Asterisks indicate significant differences between 
experimental groups (Kruskal-Wallis test with Dunn’s Multiple Comparison test; * 
p<0.05, ** p<0.01, *** p<0.001; N=340-410 total neurons analyzed from 3 animals per 
treatment group). 
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table show the relationship more precisely, with both the ATF3+ve population (injured) 
and the ATF3-ve population (uninjured) responding to both AIH and ES treatment, 
compared to normoxia controls. This effect was robust and followed the same pattern 
irrespective of whether the motor neurons were injured (17% AIH; 27% ES; 4% Norm) 
or not (11% AIH; 22% ES). This agrees with previously observed increases in BDNF in 
uninjured motor neurons with AIH treatment (Lovett-Barr et al. 2012, Satriotomo et al. 
2012, Baker-Herman et al. 2004, Hassan 2015) or with ES treatment (Al-Majed, 
Brushart, and Gordon 2000).  
 
4.1.3 Neuronal HIF-1α expression 
 With AIH treatment, HIF-1α labeling intensity increased in the uninjured ATF3-ve 
nuclei population and the injured ATF3+ve nuclei population of sensory neurons in the L4 
DRG in both the cytoplasm and the nuclei compared to the normoxia treatment group 
(Figure 4.1.3.1). It appears that there may have been an effect with AIH treatment on 
expression of HIF-1α in the perineuronal satellite glial cells and the endothelial cells. 
With ES treatment, it appears that HIF-1α is increased slightly, albeit not as high as the 
expression level observed with AIH treatment compared to normoxia in both the 
uninjured ATF3-ve and injured ATF3+ve nuclei sensory neurons in both the cytoplasm and 
nucleus. 
 In the L4 region of the spinal cord, the mean immunohistochemical labeling 
intensity of HIF-1α in the nuclei, as defined by DAPI staining, of the motor neurons of 
the ATF3-ve populations was significantly increased with either AIH treatment (59%) or 
ES treatment (64%) compared to normoxia treatment (15%) when normalized to the 
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Figure 4.1.3.1 AIH or ES treatment results in increased HIF-1! protein expression 
in sensory neurons 3 days post nerve repair. Fluorescence photomicrographs of L4 
DRG 10 µm sections processed for dual immunofluorescence to detect cytoplasmic and 
nuclear HIF-1! (green) protein levels in injured ATF3 (white) positive (ATF3+) or 
uninjured ATF3 negative (ATF3-) sensory neurons from rats that underwent a tibial 
nerve repair followed by 2 day normoxia (n=3), AIH (n=3) or 1 hour ES treatment (n=3). 
Arrows identify representative sensory neurons with (injured, full arrows) or without 
(uninjured, dashed arrows) ATF3 positive nuclei. Note: AIH and ES treatment results in 
increased expression of HIF-1! in both the cytoplasm and the nucleus compared to 
normoxia controls in injured and uninjured sensory neurons. Expression of HIF-1! also 
appears to be increased in the perineuronal satellite glial cells and the endothelial cells in 
both experimental treatment conditions compared to normoxia controls. Scale bar = 20 
µm.   
 
 
 
HIF-1! Norm AIH ES 
AIH ES Norm ATF3 
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average cytoplasmic HIF-1α expression levels  in the ATF3-ve cells in the normoxia 
treatment group (0%) (Figure 4.1.3.2, Table 4.1.3.2). However, in the cytoplasm of the 
uninjured motor neurons, only ES treatment (15%) and not AIH treatment (4%),  had a 
significant effect on expression levels compared to normoxia treatment (0%). In the 
ATF3+ve nuclei motor neuron populations, the results of both treatments were much more 
pronounced. The mean immunohistochemical labeling intensity in both the cytoplasm 
and the nuclei of these neurons increased significantly for both AIH treatment (ATF3+ve: 
18% cyto, 145% nuc) and ES treatment (ATF3+ve: 24% cyto, 146% nuc) compared to 
normoxia control treatment (ATF+ve: 4% cyto, 56% nuc). The endothetlial cells, as also 
observed in the DRG, appeared to have increased expression of HIF-1α with AIH 
treatment in the spinal cord. 
 
4.1.4 SCG10, GAP43 and BDNF in tibial nerve 
The tibial nerve was detached from the sciatic trifurcation and the silastic® tubing 
was carefully removed to expose the proximal stump of the tibial nerve injury site. The 
proximal stump was carefully sectioned longitudinally and processed for dual 
immunofluorescence for the protein of interest (SCG10, GAP43 or BDNF) and βIII 
tubulin, the latter identifying and being used to demarcate the region of the growing axon 
front in which the marker of interest immunofluorescence signal intensity was quantified. 
Further, nerve sections from all three experimental groups were mounted on the same 
slide to allow processing under identical conditions with pictures used for quantifying 
alterations in protein expression also taken under identical conditions.  
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Figure 4.1.3.2 AIH and ES treatment results in increased HIF-1α protein expression 
in motor neurons 3 days post nerve repair. Top: Fluorescence photomicrographs of 10 
µm spinal sections processed for dual immunofluorescence to detect cytoplasmic and 
nuclear HIF-1α (green) protein levels in injured ATF3 (white) positive (ATF3+) or 
uninjured ATF3 negative (ATF3-) motor neurons from rats that underwent tibial nerve 
repair followed by 2 day normoxia, AIH or 1 hour ES treatment. Arrows identify 
representative motor neurons with (injured, full arrows) or without (uninjured, dashed 
arrows) ATF3 positive nuclei. Note: AIH and ES treatment results in increased 
expression of HIF-1α in both the cytoplasm and the nucleus compared to normoxia 
controls in injured motor neurons.  AIH treatment results in increased expression of HIF-
1α in the nucleus and ES treatment results in increased expression of HIF-1α in both the 
cytoplasm and the nucleus compared to normoxia controls in uninjured motor neurons.  
Additionally, a notable increase in expression of HIF-1α is observed in the endothelial 
cells with AIH treatment, with a slight increase observed with ES treatment compared to 
normoxia controls. Scale bar = 30 µm. Bottom: Graph depicts quantification of relative 
changes in the cytoplasmic and nuclear immunofluorescence levels for HIF-1α  in motor 
neurons with or without ATF3 positive nuclei in lumbar spinal cord from rats treated with 
either AIH or ES and compared to normoxia controls post-tibial nerve repair. The data is 
normalized to the mean of the motor neurons from the normoxia treatment group without 
ATF3 positive nuclei (i.e. uninjured). Asterisks indicate significant differences between 
experimental groups (Kruskal-Wallis test with Dunn’s Multiple Comparison test; 
*p<0.05, ** p<0.01, *** p<0.001; N= 322-387 total neurons analyzed from 3 animal per 
treatment group).  
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Cytoplasmic HIF-1α in Motor Neurons 
Treatment Normoxia AIH ES 
Mean immunofluorescence 
signal intensity ATF3+ve cells 
1.04 +/- 
0.0141 s.e.m. 
1.18 +/- 
0.0201 s.e.m. 
1.24 +/- 
0.0210 s.e.m. 
# of cells 173 164 165 
# of animals 3 3 3 
Significance (p) - p<0.001 p<0.001 
Mean immunofluorescence 
signal intensity ATF3-ve cells 
1.00 +/- 
0.0109 s.e.m. 
1.04 +/- 
0.0146 s.e.m. 
1.15 +/- 
0.0159 s.e.m. 
# of cells 214 158 175 
# of animals 3 3 3 
Significance (p) - p>0.05 p<0.001 
Nuclear HIF-1α in Motor Neurons 
Treatment Normoxia AIH ES 
Mean immunofluorescence 
signal intensity ATF3+ve cells 
1.56 +/- 
0.0295 s.e.m. 
2.45 +/- 
0.0497 s.e.m. 
2.46 +/- 
0.0484 s.e.m. 
# of cells 173 164 165 
# of animals 3 3 3 
Significance (p) - p<0.001 p<0.001 
Mean immunofluorescence 
signal intensity ATF3-ve cells 
1.15 +/- 
0.0191 s.e.m. 
1.59 +/- 
0.0201 s.e.m. 
1.64 +/- 
0.0286 s.e.m. 
# of cells 214 158 175 
# of animals 3 3 3 
Significance (p) - p<0.001 p<0.001 
 
Table 4.1.3.2 In the L4 region of the spinal cord, the mean immunohistochemical 
labeling intensity of HIF-1α in the nuclei of the motor neurons of the ATF3-ve 
populations was significantly increased with either AIH treatment or ES treatment 
compared to normoxia treatment (Figure 4.1.3.2). However, in the cytoplasm of the 
motor neurons, only ES treatment, not AIH treatment,  had a significant effect on 
expression levels compared to normoxia treatment. In the ATF3+ve  nuclei motor neuron 
populations, the results of both treatments were much more pronounced. The mean 
immunohistochemical labeling intensity in both the nucleus and the cytoplasm increased 
significantly with both AIH treatment and ES treatment compared to normoxia treatment. 
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Differences between the treatment groups were observed; AIH and ES treatment 
as normalized to the normoxia control group showed significant increases in levels of 
GAP43 (16% AIH; 34% ES) and SCG10 (45% AIH; 83% ES) immunofluorescence 
detected; while for BDNF protein expression ES showed a modest increase in BDNF 
(8%) immunolabeling intensity, whereas AIH treatment did not (Figure 4.1.4, Table 
4.1.4). 
Unlike GAP43 and SCG10, BDNF expression was notably dispersed throughout 
the nerve region proximal to injury and not primarily confined to the growing axon front 
in both experimental treatment groups,  (Figure 4.1.4) raises the possibility of altered 
retrograde or anterograde axonal transport for this protein, relative to the other two 
examined. 
 
4.2 Impact of AIH or ES versus normoxia treatment on tibial nerve regeneration 
4.2.1 Retrograde labeling of regenerating sensory and motor neurons 
 The tibial nerve was exposed to 2% FG in saline solution in a Vaseline well, a 
technique previously used by colleagues for dye uptake (Al-Majed et al. 2000). The 
topographic distribution of the fluorescent FG positive motor neurons contributing to the 
tibial nerve was within the upper two thirds of the lateral aspect of the ventral horn of the 
spinal cord (Figure 4.2.1). There was significant variability (25%) in the total number of 
FG-labeled motor neurons (1150 +/- 296) indicating that an increase in the size of the 
mould used for spinal cord sections reduce the likelihood of missing some motor neurons 
at the most rostral or caudal portions in some animals. Alternatively, processing the 
spinal cord in two separate sections to be able to increase the length of the spinal cord  
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Figure 4.1.4 AIH or ES treatment results in increased SCG10, GAP43 and BDNF 
protein expression in the tibial nerve proximal tip 3 days post nerve repair. Top: 
Fluorescence photomicrographs of 10 µm tibial nerve sections processed for dual 
immunofluorescence to detect SCG10, GAP43 and BDNF (all green) and "IIItubulin (not 
shown) protein levels in rats that underwent tibial nerve repair followed by 2 day 
normoxia, AIH or 1 hour ES treatment. This portion of the tibial nerve is encapsulated 
within the silastic tubing and sutured to the distal stump which may shift or detach during 
processing. The distal stumps can be observed in some of the AIH and ES 
photomicrographs above. Note: SCG10 and GAP43 appear more prominent at the 
Norm 
AIH 
SCG10 
Norm AIH ES 
Norm 
Norm 
AIH 
AIH 
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ES 
Proximal Tip 
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proximal tip. BDNF appears throughout the proximal nerve as well as at the proximal tip. 
Scale bars = 1 mm Bottom: Graph depicts quantification of relative changes in the axonal 
immunofluorescence levels at the proximal tip (as identified by an established threshold 
of increased βIIItubulin labeling) of SCG10, GAP43 and BDNF from rats treated with 
either AIH or ES and compared to normoxia controls post-tibial nerve repair. The data is 
normalized to the mean labeling intensity from the normoxia treatment group. Asterisks 
indicate significant differences between experimental groups (Kruskal-Wallis test with 
Dunn’s Multiple Comparison test; * p<0.05, ** p<0.01, *** p<0.001; N= 4 animals per 
treatment group). 	
 
 
 
 
SCG10 in Proximal Stump 
Treatment Normoxia AIH ES 
Mean immunofluorescence 
signal intensity 
1.00 +/- 
0.0278 s.e.m. 
1.45 +/- 
0.0673 s.e.m 
1.83 +/- 
0.1784 s.e.m. 
# of animals 4 4 4 
Significance (p) - p<0.01 p<0.05 
GAP43 in Proximal Stump 
Treatment Normoxia AIH ES 
Mean immunofluorescence 
signal intensity 
1.00 +/- 
0.1035 s.e.m. 
1.16 +/- 
0.0487 s.e.m. 
1.34 +/- 
0.0596 s.e.m. 
# of animals 4 4 4 
Significance (p) - p<0.05 p<0.01 
BDNF in Proximal Stump 
Treatment Normoxia AIH ES 
Mean immunofluorescence 
signal intensity 
1.00 +/- 
0.1255 s.e.m. 
1.08 +/- 
0.0460 s.e.m. 
1.08 +/- 
0.0238 s.e.m. 
# of animals 4 4 4 
Significance (p) - p>0.05 p<0.05 
 
Table 4.1.4 The mean immunohistochemical labeling intensity of SCG10 expression 
with AIH treatment or ES treatment normalized to normoxia treatment increased 
significantly. The mean labeling intensity of GAP43 expression with AIH treatment or 
ES treatment normalized to normoxia treatment increased significantly. The mean 
labeling intensity of BDNF expression with ES treatment normalized to normoxia 
treatment increased significantly. With AIH treatment, it did not. 
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Figure 4.2.1 Impact of AIH or ES treatment on numbers of regenerating motor and 
sensory neurons following tibial nerve repair. Top Left: Fluorescence 
photomicrographs of 10 µm sections of the right L3 to L5 spinal cord and the right L4 
DRG processed for visualization of the FG (white labeled cells) retrograde tracer 
distribution in rats that underwent tibial nerve repair followed by 2 day normoxia, AIH or 
1 hour ES treatment. The tibial nerve was transected and the proximal stump soaked in 
FG for an hour before it was repaired (n=6) to establish baseline numbers of motor and 
sensory neurons contributing to the tibial nerve in the L3 to L5 spinal cord and the L4 
DRG. The animals were killed 30 days post nerve repair and every 2nd 10 µm section was 
counted. A second group of animals underwent tibial nerve repair followed by 2 day 
normoxia (n=4), AIH (n=4) or 1 hour ES treatment (n=5) and at 25 days post-nerve 
repair, the tibial nerve was transected 28 +/- 1 mm distal from the repair site and the 
stump was soaked in FG for an hour. The animals were also killed 30 days post nerve 
repair and every 2nd 10 µm section was counted. Top Right: Table shows the total 
number of sensory neurons in the L4 DRG, the total number of FG (repair site) labeled 
motor neurons from the L3 to L5 spinal cord, the total number of FG (repair site) labeled 
sensory neurons in the L4 DRG, the number of FG labeled regenerated (distal tibial 
nerve) motor and sensory neurons in animals treated with 2 day normoxia, AIH or 1 hour 
ES. Note: FG labeled regenerated motor and sensory neurons are not significantly 
different between treatment groups.  
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section collected from L2 to L6 is an option. This variability in in the numbers of 
retrogradely motor neurons  neurons was not evident in the sensory neuron counts from 
L4 DRG examined. The fluorescent FG positive sensory neurons were largely uniformly 
distributed throughout the ganglia save for the dorsal region and one small lateral portion 
having very few fluorescent cells (data not shown). Quantification of the FG-labeled cells 
revealed consistent total number of sensory neurons contributing to the tibial nerve with 
low variability (4514 +/- 363, 8% variability), also reflected in the low variability 
observed for the total number (FG labeled and unlabeled) of L4 ganglia sensory neurons 
(8767 +/- 825, 9% variability) in adult Lewis male rats of the same age and similar 
weight (average 347 grams +/- 38 grams) (Figure 4.2.1).  
For assessment of regeneration at long-term time-points, exposure of the lower 
tibial nerve to 2% FG in saline solution, the Vaseline well technique was initially 
attempted. Unfortunately, due to the small size of the nerve and the lack of a position to 
place the Vaseline well below the level of the nerve to prevent capillary action, the dye 
ended up being taken up systemically. Therefore, a 4 mm silastic cuff with medical grade 
silicon glue plug on one end was employed (Elzinga et al. 2015). There was some 
difficulty isolating all of the collateral sprouting branches of the regenerating tibial nerve 
as we observed multiple branches arising at the level where the gastrocnemius and soleus 
muscles begin to transition to the Achilles tendon and as they proceed distally, become 
deeply intertwined with capillaries branching from the posterior tibial artery. FG dye 
visualization at the level of the sensory and motor neuron cell bodies when introduced 28 
+/ 1 mm from the repair site was low to moderate compared to visualization when 
introduced at the repair site. Quantification of the FG-labeled motor neurons in the 
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ventral horn of the L3 to L5 segments of spinal cord revealed that an average 359 +/- 42 
(normoxia n=4), 428 +/- 83 (AIH n=4) and 478 +/- 120 motor neurons (ES n=5) axons 
regenerated a minimum distance of 28 +/- 1 mm distal to the tibial nerve repair site 25 
days post-repair. While elevated numbers of regenerating motor neurons were detected in 
the two treatment groups relative to normoxia controls, they did not reach statistical 
significance (normoxia n=4; AIH n=4; and ES n=5; Figure 4.2.1). Similarly, the numbers 
of retrogradely labeled regenerating L4 DRG neurons ipsilateral to lesion were not 
significantly different, despite also being elevated in the two treatment groups (normoxia 
571 +/- 51 n=3; AIH 639 +/- 74 n=4; and ES 746 +/- 42 FG n=4).  
 
4.2.2 Regeneration of tibial nerve axons  
 One µm semi-thin cross section of the tibial nerve from a 3 mm sample taken at 
20 mm from the original repair site (the center or the location of the suture knot on the 
silastic® tube) or 25 mm from the sciatic trifurcation was photographed and quantified at 
the light microscopy level from each animal. Despite being taken at the same anatomical 
distance from the repair site and with no significant variances in weight existing between 
animals throughout the experiment, the regenerated tibial nerve cross sections revealed 2 
ES, 2 Norm and 3 AIH animals had a single fascicled tibial nerve, 2 ES and 2 Norm 
animals had a bi-fascicular tibial nerve and 1 AIH had a tri-fascicular tibial, all of which 
were encased in continuous connective tissue (Figure 4.2.2). Initial qualitative 
observations of the distribution and density of myelinated axons lead us to attempt to do a 
preliminary quantification and classification.  Quantification included heavily myelinated 
and lightly myelinated axonal profiles. Due to the limitations of light microscopy,  
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Average # of Tibial Visible Regenerated Myelinated Axons per Animal 
Treatment Norm (n=4) AIH (n=4) ES (n=4) 
# of myelinated 
axons 1684 +/- 81 s.e.m. 2007 +/- 36 s.e.m. 2042 +/- 70 s.e.m. 
Significance - p<0.05 p<0.01 
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Figure 4.2.2 Impact of AIH or ES treatment on numbers of regenerating axonal 
fibers following tibial nerve repair. Top and Middle: Bright field photomicrographs of 
transverse 1 µm toluidine blue counterstained semi-thin sections of contralateral or 
ipsilateral tibial nerve 20 mm from the repair site 25 days following tibial nerve repair in 
rats that underwent 2 day normoxia, AIH or 1 hour ES treatment with magnified view on 
the top and the full montage in the middle. Scale bars: 5 and 200 µm respectively. 
Bottom: Table shows the total number of myelinated axons from the regenerated tibial 
nerves. Significant differences were observed in the number of myelinated profiles 
between AIH and Norm treatment groups and between ES and Norm treatment groups. 
Unmyelinated and very heavily myelinated profiles were not quantified. One 1 µm semi-
thin section from each animal was counted in 12 animals total (normoxia n=4, AIH n=4, 
ES n=4).  
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unmyelinated axons could not be assessed. Thus, only the total of light and medium 
myelinated profiles’ analyses are shown (Figure 4.2.2) with a significant difference in 
myelinated profiles between AIH (n=4) compared to Norm (n=4) treatment as well as ES 
(n=4) compared to Norm (n=4) treatment. It is noted that in order to differentiate the 
unmyelinated morphological structures from lipid globules or macrophage debris, 
additional processing with immunofluorescence for neurofilament proteins will need to 
be done. Furthermore, heavily myelinated profiles appear very similar to degenerating 
neuronal profiles at the light microscopy level and thus, we were unable to decipher 
between them for the purpose of this study. We did however quantify them and ES 
treatment (95 +/- 15) appears to have significantly more heavily myelinated axons or 
degenerating axon profiles than AIH (37 +/- 3) or Norm (47 +/- 4) treatment groups 
(Figure 4.2.2). Castro, Negredo, and Avendano (2008) showed that with toluidine blue 
staining, under a light microscope, certain axonal profiles may appear as heavily 
myelinated whereas when the same section is viewed at the electron microscopy level, it 
becomes evident that these are in fact degenerating profiles. Thus, subsequent processing 
and quantification will need to be done on these nerve cross sections to conclude with 
any accuracy as to what is happening in regards to heavily myelinated, unmyelinated 
nerve fibers and degenerating profiles. Further investigation is warranted, but beyond the 
scope of this thesis.  
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4.3 Impact of AIH or ES versus normoxia treatment on regeneration- and pain-
associated behavioural responses 
For the initial two weeks post-surgery, it was challenging to have the rats position 
their right hind limb down on the testing surface. With a tibial nerve injury, rats typically 
evert their footpad so that the lateral portion (digits 4 and 5) only contacts the ground 
with rats guarding it and/or choosing to hop with the other three limbs rather than fully 
set the right hind limb down. In the cases when some of the rats would not set their right 
hind limb down on the testing surface (Von Frey and Hargreaves) after a 20 minute 
period, a treat was given to all the rats from above that required them to stand on their 
hind limbs and use their forelimbs to retrieve it. Once the treat was consumed, the testing 
resumed as their hind limbs would remain on the testing surface after they returned to a 
quadruped position. 
The development of neuropathic pain states after a variety of nerve injuries in 
experimental rats has been shown to be strain specific by numerous researchers (DeLeo 
and Rutkowski 2000, Wiesenfeld and Hallin 1981, Lee, Chung, and Chung 1997, 
Herradon et al. 2008). Amongst all of the strains, our experimental strain, the Lewis rat, 
is seemingly one of the more responsive to neuropathic pain from nerve injuries. 
Following a priming trigeminal nerve injury, the Lewis strain demonstrated an 
accelerated development of hind paw mechano-allodynia and mechanohyperalgesia after 
a sciatic nerve chronic constriction injury compared to the Sprague-Dawley and Sabra 
strains (Benoliel, Eliav, and Tal 2002). With the same injury, without priming, the Lewis 
strain has sustained mechanical allodynia for much longer than the Fischer 344 strain of 
rats (Herradon et al. 2008). Thus, we believe that in addition to being a rat strain that 
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responds to AIH treatment, it is an ideal strain, due to its heightened sensitivity, to test 
any possible neuropathic side effect of the AIH treatment. 
 
4.3.1 Thermal hyperalgesia at mid-term  
Because of the previously identified impact of BDNF on neuropathic pain states 
and thermal hyperalgesia (Uchida, Matsushita, and Ueda 2013), it was imperative to 
determine whether or not the observed AIH- and ES-induced significant increases in 
BDNF expression levels in peripheral nerves were creating a physiological heightened 
sensitivity to nociceptive input.  
Mid-term thermal hyperalgesia analysis revealed no statistically significant 
differences between the right hind limbs (injured), the left hind limbs (non-injured) nor 
one to the other, in tibial nerve repaired animals subjected to normoxia, AIH or ES 
treatments [N=6 tests x 5 trials per hind limb in 14 animals total (uninjured control n=2, 
normoxia n=4, AIH n=4, ES n=4); Figure 4.3.1]. Additionally, the anticipated change in 
withdrawal time of the right hind limb from the infrared heat source immediately post-
tibial nerve repair on day 4 was not observed as all animals including the non-injured 
control animals performed similarly (control: 11.16 sec. +/- 2.50 s.e.m., normoxia: 10.80 
+/- 1.86, AIH: 11.76 +/- 2.32 and ES: 8.80 +/- 0.92). It appears that thermal sensory 
nociceptive input from the footpad is not significantly affected with this tibial nerve 
injury and repair model. Thermal hyperalgesia testing was repeated in the long-term 
study to support or discount the phenomenon observed with this study. 
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Figure 4.3.1 AIH and ES treatments do not increase thermal hypersensitivity in 
tibial nerve repaired animals. Graph depicting temporal differences in mean 
withdrawal time (seconds) tested by Hargreaves infrared apparatus as a function of 2 day 
normoxia, AIH or 1 hour ES treatment in the right (injured) and the left (uninjured) hind 
limbs. Tibial nerve transection and repair was performed on Day 0 with one baseline 
measurement taken during the week prior. ES (blue arrow) was done immediately after 
tibial repair. AIH or normoxia was administered on days 2 and 3 (red arrows). Note: 
There were no statistically different withdrawal times between groups during any of the 
testing time points from baseline to 25 days post-injury (N=6 tests x 5 trials per hind limb 
in 14 animals total (uninjured control n=2, normoxia n=4, AIH n=4, ES n=4)).  
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4.3.2 Mechanical hyperalgesia at mid-term 
 Unlike the thermal hyperalgesia testing results, mechanical hyperalgesia was 
significantly affected by tibial nerve repair surgery with a decrease in withdrawal  
pressure observed in the three treatment groups by an average of 20 grams on day 5 
compared to baseline (normoxia p<0.01, AIH p<0.0001, ES p<0.001) (Figure 4.3.2). No 
recovery to baseline withdrawal pressure nor statistically significant differences were 
observed between the normoxia, AIH or ES treatment groups over the 25 day testing 
period (N=6 tests x 4 trials per hind limb in 14 animals total (uninjured control n=2, 
normoxia n=4, AIH n=4, ES n=4)). Therefore, mechanical hyperalgesia was retested 
during the long-term study to observe whether any mechanical proprioceptive recovery 
may occur at a later time-point. 
 
4.3.3 Ladder crossing test at mid-term 
It was anticipated that AIH might improve horizontal ladder walking ability in 
peripherally injured Lewis rats as 7 days of AIH has been shown to reduce forelimb 
footslip errors when administered 4 weeks post-spinal cord injury in the same strain. This 
recovery was maintained at 1 and 3 weeks after the daily AIH treatments (Lovett-Barr et 
al. 2012). In the present study, there were no significant differences observed in the mean 
percentage of correct steps on the horizontal ladder task between the treatment groups at 
3 weeks post-injury (N=3 tests per week x 10 crossings in 14 animals total (uninjured 
control n=2, normoxia n=4, AIH n=4, ES n=4)) (Figure 4.3.3). Immediately after the 
tibial nerve repair (week 1 day 1), a significant decrease in the correct steps with the right 
hind limb was observed in the three treatment groups but this margin of error was quickly 
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Figure 4.3.2 AIH and ES treatments do not increase mechanical hypersensitivity in 
tibial nerve repaired animals. Graph depicting temporal differences in mean 
withdrawal pressure (grams) tested by Von Frey fiber as a function of 2 day normoxia, 
AIH or 1 hour ES treatment in the right (injured) and the left (uninjured) hind limbs. 
Tibial nerve transection and repair was performed on Day 0 with one baseline 
measurement taken during the week prior. ES (blue arrow) was done immediately after 
tibial repair. AIH or normoxia was administered on days 2 and 3 (red arrows). Note: 
There were no statistically different withdrawal pressures between groups during any of 
the testing time points from baseline to 25 days post-injury (N=6 tests x 4 trials per hind 
limb in 14 animals total (uninjured control n=2, normoxia n=4, AIH n=4, ES n=4)). 
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Figure 4.3.3 AIH and ES treatments do not improve the percent correct steps in 
tibial nerve repaired animals. Graph depicting temporal differences in mean % correct 
steps on ladder walking as a function of 2 day normoxia, 2 day AIH or 1 hour ES 
treatment in the right (injured) and the left (uninjured) hind limbs. Tibial nerve 
transection and repair was performed on Day 0 with three baseline measurements taken 
during the week prior. ES (blue arrow) was done immediately after tibial repair. AIH or 
normoxia was administered on days 2 and 3 (red arrows). Note: There were no 
statistically different percent correct steps between groups during any of the testing time 
points from baseline to 25 days post-injury (N=3 tests per week x 10 crossings in 14 
animals total (uninjured control n=2, normoxia n=4, AIH n=4, ES n=4)). 
 
 
 
 102 
rectified by 20% the next testing session. All treatment groups demonstrated a similar 
pattern in the ladder-walking task throughout the 25 days testing session as no significant 
differences were observed between groups. In the left hind limb, the percentage of correct 
steps was above 95%. In contrast, with the reduced use of the right hind limb, the rats 
appeared rather unstable in their forelimb grasps on the horizontal ladder, generating a 
wide range of correct steps versus incorrect steps with no particular pattern by both 
forelimbs throughout the 25 days. It is believed that differences in treatments groups in 
right hind limb performance on the horizontal ladder task may be observed at a later time 
point.   
 
4.3.4 Walking footprint analysis at mid-term  
The magnitude of tibial nerve reinnervation in relation to right hind limb footpad 
positioning was shown to not be very advanced as only an insignificant slight average 
improvement was observed in the tibial nerve index function 25 days post injury 
compared to previous testing sessions (Figure 4.3.4). Despite the minor change in toe 
spread and footpad positioning, no significant differences of the tibial nerve index 
function were observed between the two treatment groups, AIH and ES, compared to the 
normoxia control group (N=3 tests per week x 3 prints per hind limb in 14 animals total 
(uninjured control n=2, normoxia n=4, AIH n=4, ES n=4)) (Figure 4.3.4). It is believed 
that with additional time to regenerate of a few weeks, significant differences may be 
observed. Accordingly, the long-term investigation of 10 weeks was undertaken.  
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 Baseline  Week 1  Week 2  Week 3 
 
Figure 4.3.4 Impact of AIH or ES treatment on tibial nerve index functional 
recovery in tibial repaired animals. Top: Representative footprints from ES treatment 
rats ipsilateral to repair (days post repair as indicated). Blue lines show representative 
length of print, 1st to 5th toe spread and 2nd to 4th toe spread measurements. Bottom: 
Graph depicting temporal differences in tibial nerve index function in relation to 2 day 
normoxia, AIH or 1 hour ES treatment. Tibial nerve transection and repair was performed 
on Day 0 with three baseline measurements taken during the week prior. ES (blue arrow) 
was done immediately after tibial repair. AIH or normoxia was administered on days 2 
and 3 (red arrows). Note: Three weeks post-injury, the tibial nerve index function for the 
ES and AIH treatment groups are not significantly different from the normoxia treatment 
group (N=3 tests per week x 3 prints per hind limb in 14 animals total (uninjured control 
n=2, normoxia n=4, AIH n=4, ES n=4)). 
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4.3.5 Thermal hyperalgesia at long-term  
The results of the thermal hyperalgesia testing session extended to 10 weeks 
confirmed the observations from the mid-term study. There were no statistically 
significant differences in thermal hyperalgesia as indicated by withdrawal times from an 
infrared Hargreaves heat source between groups during any of the testing time points 
from injury to ten weeks post-injury (N=1 test per week x 5 trials per hind limb in 18 
animals total (uninjured control n=4, normoxia n=5, AIH n=5, ES n=4)) (Figure 4.3.5). 
However, unlike the mid-term study that showed a slight overall decrease in the 
withdrawal time between baseline and day 23 of testing, the long-term study showed an 
overall acclimatization to the testing apparatus as evidenced by the average withdrawal 
time steadily increasing 1.72 seconds after 3 weeks and 5.57 seconds after 10 weeks from 
baseline. Immediately after the tibial nerve repair, on week 1, there was a negligible 
change in withdrawal time, decreasing it an average of 0.46 seconds compared to 
baseline. Once again, there were no differences observed between the right and left hind 
limbs in any of the treatment conditions so it appears that the tibial nerve repair model 
does not affect thermal hyperalgesia.  
 
4.3.6 Mechanical hyperalgesia at long-term 
 Similar to the mid-term mechanical hyperalgesia testing session, all three 
treatment groups, normoxia, AIH and ES, showed no significant differences in 
withdrawal pressure during any of the treatment days over the course of the long-term 
study (N=1 test per week x 4 trials per hind limb in 18 animals total (uninjured control 
n=4, normoxia n=5, AIH n=5, ES n=4)) (Figure 4.3.6). Unlike the mid-term results, the  
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Figure 4.3.5 AIH and ES treatments do not increase thermal hypersensitivity in 
tibial nerve repaired animals. Graph depicting temporal differences in withdrawal time 
(seconds) tested by Hargreaves infrared apparatus as a function of 2 day normoxia, AIH 
or 1 hour ES treatment in the right (injured) and the left (uninjured) hind limbs. Tibial 
nerve transection and repair was performed on Day 0 with baseline measurements taken 
during the week prior. ES (blue arrow) was done immediately after tibial repair. AIH or 
normoxia was administered on days 2 and 3 (red arrows). Note: There were no 
statistically significant differences in thermal hyperalgesia as indicated by withdrawal 
times from an infrared Hargreaves heat source between groups during any of the testing 
time points from injury to ten weeks post-injury (N=1 test per week x 5 trials per hind 
limb in 18 animals total (uninjured control n=4, normoxia n=5, AIH n=5, ES n=4)). The 
tibial nerve injury had a small impact on withdrawal time, decreasing it an average of 
0.46 seconds compared to baseline on the first week of testing. As time progressed, all 
treatment groups became further acclimatized to the testing apparatus as evidenced by the 
average withdrawal time steadily increasing 5.57 seconds from baseline after 10 weeks. 
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Figure 4.3.6 AIH and ES treatments do not increase mechanical hypersensitivity in 
tibial nerve repaired animals. Graph depicting temporal differences in withdrawal 
pressure (grams) tested by Von Frey fiber as a function of 2 day normoxia, AIH or 1 hour 
ES treatment in the right (injured) and the left (uninjured) hind limbs. Tibial nerve 
transection and repair was performed on Day 0 with baseline measurements taken during 
the week prior. ES (blue arrow) was done immediately after tibial repair. AIH or 
normoxia was administered on days 2 and 3 (red arrows). Note: There were no 
statistically different withdrawal pressures between groups during any of the testing time 
points from injury to ten weeks post-injury (N=1 test per week x 4 trials per hind limb in 
18 animals total (uninjured control n=4, normoxia n=5, AIH n=5, ES n=4)).
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lowest average withdrawal pressure was observed on week 2 after the tibial nerve repair 
rather than the previously observed week 1. By week 10, the right hind limb withdrawal 
pressures from the Von Frey fiber do not return to pre-tibial nerve repair levels, 
remaining lower in all treatment groups. 
 
4.3.7 Ladder crossing test at long-term 
 Due to the lack of statistically significant differences between the treatment 
groups on all of the other behavioural tests as well as the mid-term results, only three  
time-points from this data set were evaluated on the ladder crossing during the long-term 
study. It was hypothesized that horizontal ladder walking performance may approximate 
baseline performance after 10 weeks but this proved to not be the case. In addition to not 
regaining full function, no statistically significant differences were observed between the 
treatment groups (N=2 tests per week x 10 crossings in 18 animals total (uninjured 
control n=4, normoxia n=5, AIH n=5, ES n=4)) (Figure 4.3.7). Because of the balancing 
required to avoid putting the right hind limb fully down with each stride, observations 
were made, akin to those noted for the mid-term study, that the accuracy of forelimb 
placement was affected non-specifically over the course of the long-term study. 
 
4.3.8 Walking footprint analysis test at long-term 
Following the completion of footprint analysis, it was concluded that footprints 
were biased in that they were selected for ‘full prints’ where the animal had slowed down 
its stride and placed its hock more firmly down on the testing track resulting in a less 
smudged and blurred print. The tibial nerve index includes measurements for the length  
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Figure 4.3.7 AIH and ES treatments do not improve the percent correct steps in the 
hind limbs of tibial nerve repaired animals. Graph depicting temporal differences in % 
correct steps on ladder walking as a function of 2 day normoxia, AIH or 1 hour ES 
treatment in the right (injured) and the left (uninjured) hind limbs. Tibial nerve 
transection and repair was performed on Day 0 with baseline measurements taken during 
the week prior. ES (blue arrow) was done immediately after tibial repair. AIH or 
normoxia was administered on days 2 and 3 (red arrows). Note: There were no 
statistically different percent correct steps between groups during any of the testing time 
points from injury to 6 weeks post-injury (N=2 tests per week x 10 crossings in 18 
animals total (uninjured control n=4, normoxia n=5, AIH n=5, ES n=4)). 
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of print, length of full toe spread from digits one to five and intermediate toe spread from 
digits two to four. Thus, for the long-term footprint analysis, the toe spread was used as 
an indication of regeneration likely due to reinnervation of the tibialis posterior, flexor 
hallucis longus and the flexor digitorum longus muscles, all contributing to supination of 
the foot, reversing the pathological pronation of the foot seen with a tibial nerve injury, 
and possible footpad sensory reinnervation.  
Normalized toe spread analysis showed the treatment groups performed similarly 
until week 5 post-tibial nerve repair (N=2 tests per week x 3 prints per hind limb in 18 
animals total (uninjured control n=4, normoxia n=5, AIH n=5, ES n=4) (Figure 4.3.8). 
From week 5 onwards, the ES treatment group was significantly different from the 
normoxia treatment group as the difference in toe spread in their hind paws (between 
their injured right hind paw and their uninjured left hind paw) was significantly reduced 
except for time-point week 7.5 and week 10.5.  At the week 6 and week 7 time points, the 
AIH treatment group’s difference in toe spread was significantly different from the 
normoxia treatment group (p<0.001 and p<0.05 respectively). It is of note that it does not 
appear that any of our treatment groups were trending towards full functional recovery of 
their right hind paw with not a single time point, even after 10 weeks having less than 7 
mm difference in toe spread from left to right when uninjured rats average 1 to 2 mm. 
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         Baseline                     Week 1             Week 4        Week 10 
 
 
Figure 4.3.8 Impact of AIH or ES treatment on hind limb toe spread functional 
recovery in tibial repaired animals. Top: Representative footprints from ES treatment 
rats ipsilateral to repair at days post repair as indicated. Blue lines show representative 
toe spread measurement. Bottom: Graph depicting temporal differences in toe spread 
measurement relative to baseline as a function of 2 day normoxia, AIH or 1 hour ES 
treatment. Tibial nerve transection and repair was performed on Day 0 with baseline 
measurements taken during the week prior. ES (blue arrow) was done immediately after 
tibial repair. AIH or normoxia was administered on days 2 and 3 (red arrow). Note: Five 
weeks post-injury, the toe spread for the ES treatment group was significantly different 
from the control group with a trend toward significance in the AIH group observed from 
week 6 on. (Kruskal-Wallis test with Dunn’s Multiple Comparison test; * p<0.05, ** 
p<0.01, *** p<0.001; N=2 tests per week x 3 prints per hind limb in 18 animals total 
(uninjured control n=4, normoxia n=5, AIH n=5, ES n=4). 
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5. Discussion 
 
This thesis tested the hypothesis that AIH will serve as an effective adjunct 
therapy to promote improved regeneration of surgically repaired peripheral nerves in a 
manner akin to that observed with brief nerve ES. The experiments herein addressed the 
biological, morphological and behavioural affects of AIH or ES treatment compared to 
control normoxia treatment following a peripheral nerve injury and repair involving the 
tibial nerve.  In the first section, the short-term effects of AIH or ES versus normoxia 
control treatment on RAGs were assessed and quantified. Next, the regenerative potential 
induced by these experimental and normoxia control treatments was investigated using 
retrograde fluorescent tracer to label both the regenerating sensory and motor neurons 25 
days after repair 28 mm from the original repair site.  Finally, a series of behavioural 
experiments were conducted for each treatment paradigm on two timelines, 25 days and 
10 weeks, to assess the changes in the anatomical positioning of the rats’ hind limb when 
walking, as well as changes in sensory innervation of the footpad in terms of responses to 
thermal and mechanical stimuli.  
 
5.1 Summary of major findings 
 The results of this thesis revealed that: 1) 2 days of AIH or 1 hour immediate ES 
treatment significantly increases RAGs in the repaired peripheral nerve, tibial nerve-
associated neuronal cell bodies and in some cases, non-associated neuronal cell bodies in 
the DRG and spinal cord regions examined; 2) AIH or ES treatment significantly 
increases the numbers of regenerated myelinated axonal profiles observed 25 days post-
injury 20 mm from the repair site; 3) AIH or ES treatment do not elevate neuropathic 
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pain states associated with the nerve injury and repair, as assessed by mechanical- and 
thermal- hyperalgesia behavioural tests; 4) AIH or ES treatment promote the 
reestablishment of toe spread during the stance phase of walking in the recovering hind 
limb post-repair.  
 
5.2 RAG changes with AIH and ES treatment 
The robust changes in RAG expression in response to AIH or ES relative to the 
normoxia controls were observed 72 hours post-tibial nerve transection and repair (one 
hour after completion of the 2nd AIH treatment) and included elevated GAP43, BDNF, 
ATF-3, HIF-1α and SCG10. These alterations were observed in associated sensory and 
motor neuron cell bodies and in some cases, even in non-associated neurons (i.e. not 
contributing to the tibial nerve) in the L4 DRG and lumbar spinal cord levels examined. 
The timeframe of the observed response is consistent with the rapid activation of injury-
associated transcription factors and subsequent expression of target regeneration-
associated proteins that drive or modulate the repair of the injured axons (reviewed in 
Raivich 2011) and that were previously reported to be induced in response to ES at the 
same time-point in our previous studies (Geremia et al. 2007, Al-Majed, Brushart, and 
Gordon 2000, Al-Majed et al. 2000).  
Of the regeneration-associated factors investigated, SCG10 has the most rapid 
response post-injury. Shin et al. (2012) have reported that levels increase dramatically 
and selectively in the sensory versus motor axons proximal to injury within an hour 
following a peripheral nerve transection, and continue to rise until 3 hours post-injury 
when they plateau, with labeling observed in the central region of individual growth 
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cones by 5 hours (Shin, Geisler, and DiAntonio 2014). My investigations confirm that 
SCG10 levels are still elevated 72 hours post-repair, and significantly increased by both 
treatment modalities, ES and AIH, at the growing axon front. In contrast, we did not 
observe any discernible SCG10 labeling in the distal tibial nerve stump in 72 hour injured 
and repaired nerves, consistent with the reported 80% decrease in SCG10 observed only 
3 hours post-injury likely due to its selective loss in response to JNK-dependent 
degradation (Shin et al. 2012).  Thus, relative to other markers of axon regeneration 
which remain fragmented in the distal nerve stump, such as βIII-tubulin or neurofilament 
(Beirowski et al. 2005), SCG10 cleanly labels the regenerating sensory axon front. 
Further, as SCG10 is a destabilizing factor linked to efficient axon outgrowth, the 
dynamic axon state induced by its elevated expression in response to ES and AIH likely 
benefits regrowth of the injured axons (Morii, Shiraishi-Yamaguchi, and Mori 2006), the 
former consistent with that previously reported in response to long term potentiation 
events in hippocampal pathways (Peng, Derrick, and Martinez 2003, 2004). 
With a similar time frame of upregulation as SCG10 post-injury, the transcription 
factor HIF-1α is normally quickly degraded by the ubiquitin-proteasome system in the 
non-injured cell under conditions of normoxia (at atmospheric oxygen levels), having a 
half life of only approximately 5 minutes (Salceda and Caro 1997). However, under 
hypoxic conditions, HIF-1α is activated within the cell, translocated from the cytoplasm 
to the nucleus where it forms the HIF heterodimer complex protein by binding with HIF-
1β which is constitutively expressed (Lando et al. 2002, reviewed in Masoud and Li 
2015). HIF-1α plays a crucial role in the initiation of an adaptive response by triggering a 
cascade of transcriptional gene changes, including energy metabolism, cellular 
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homeostasis and mitochondrial modulation. Using an exogenously administered probe, 
hypoxyprobe-1, that allows for the in vivo monitoring of hypoxic conditions when 
oxygen levels are below 10 mmHg (Gross et al. 1995),  an area of severe hypoxia was 
observed to co-localize with axons, macrophages and Schwann cells at the injury site and 
distally within 2 hours and 3 days later, was also evident distal to the lesion site (Lim et 
al. 2015). In my doctoral studies, I found that that both AIH and ES treatments elevated 
expression levels of the transcription factor HIF-1α in spinal cord motor neurons beyond 
that seen in the peripheral nerve and repair only controls +/- normoxia treatment. 
Hypoxia has been previously shown to induce expression of HIF-1α in a variety of cell 
types including spinal motor neurons, sensory neurons, endothelial and Schwann cells 
(Cho et al. 2015, Yang et al. 2014, Satriotomo et al. 2016, Zhang et al. 2013). While the 
expression levels of HIF-1α in the DRG with AIH or ES treatment were not quantified, a 
qualitative increase in expression in the cytoplasm and nucleus of injured and uninjured 
sensory neurons as well as the endothelial cells was observed with both treatment 
paradigms. While the mechanisms underlying the observed increased expression was not 
addressed in this thesis, HIF-1α’s transcription rate has been shown to be regulated by 
various signal transduction pathways including that of Ca2+ (Mottet et al. 2003). Thus, it 
is possible that the elevated levels of intracellular Ca2+ generated by ES stimulation were 
sufficient to upregulate HIF-1α to levels comparable to those seen with AIH treatment 
(Luo et al. 2014, Cheng et al. 2010). Finally, while this study represents the first to 
examine the regulation of HIF-1α expression in the regenerating peripheral nerve in 
response to ES, sciatic nerve stimulation or exercise in combination with 8% oxygen 
hypoxia have both been associated with rises in HIF-1α protein expression in Western 
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blot analysis in gastrocnemius muscle, however with hypoxia alone, no upregulation is 
observed (Tang et al. 2004). 
The timeline of activation of the transcription factor ATF3 in sensory and motor 
neurons is rapid, yet dependent on the distance of the axonal injuries. It is described as 
either not expressed or weakly expressed in non-injured nerve tissue and it is 
significantly upregulated post-injury in both humans and rodents (Gey et al. 2016, 
Tsujino et al. 2000). Unlike c-jun, ATF3 is not induced trans-synaptically and is therefore 
appreciated as an excellent marker of nerve injury (Tsujino et al. 2000). Three days post-
injury, it has been shown that the expression levels of roughly 20-25% of the RAGs 
modulated by a peripheral nerve injury are dependent on ATF3, as demonstrated in a 
gene-knockout model which also showed impaired regeneration (Gey et al. 2016). In this 
study, we observed a qualitative increase in ATF3 expression with AIH and even more so 
with ES treatment. An increase in NGF post-peripheral nerve injury has been shown to be 
ATF3 dependent (Gey et al. 2016) with NGF being necessary for the sprouting of nerve 
fibers (Romero et al. 2000). 
Exogenous application of growth factors has been demonstrated to increase 
peripheral nerve regeneration (Boyd and Gordon 2002, 2003). The therapeutic strategies 
used in this thesis namely ES or AIH both stimulated endogenous production of BDNF 
which has been shown to be induced rapidly in sensory neurons post-injury (Karchewski 
et al. 2002) and has also been shown to be critical for the induction of a regenerative state 
in sensory and motor neurons (Geremia et al. 2010, Verge 2004). In terms of mechanism, 
BDNF, has been shown to be upregulated in a serotonin-dependent manner with AIH 
treatment (Baker-Herman et al. 2004) or speculated to be directly elevated by ES 
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treatment through the activation of L-type voltage sensitive Ca2+ channels of the non-N-
methyl-D-aspartate subtype of glutamate receptor (Al-Majed, Brushart, and Gordon 
2000).  
AIH appeared to have a greater effect on neuronal BDNF expression levels, 
suggesting that AIH works in conjunction with injury factors elevating expression levels 
beyond that observed with injury alone. This amplified BDNF expression was most 
notable in the smaller sensory neuron population (<30 µm diameter), the same size 
neuron that also expresses higher levels two days post-axotomy, relative to other size 
ranges of injured neurons (Karchewski et al. 2002). AIH treatment also resulted in more 
modest increases in BDNF expression in the non-injured (ATF3-ve) sensory neuron cell 
bodies within the same section of the L4 ganglia, whereas ES treatment did not, further 
supporting a systemic impact of AIH.  
Injured motor neurons have been shown to increase expression of BDNF 
following ES treatment as well (Al-Majed, Brushart, and Gordon 2000). Surprisingly, 
phrenic motor neurons (C3 to C5) and their surrounding neuropil in proximity to an 
injury (a C2 spinal cord hemi-section) when treated with daily AIH did not further 
increase their expression of BDNF beyond that observed with injury alone (81% 
increase) or daily AIH alone (45% increase) compared to uninjured normoxia treated rats 
(Lovett-Barr 2008). This is in contrast to our findings as we observed a 6% increase in 
BDNF expression with AIH treatment in injured lumbar motor neurons compared to their 
uninjured neighbors.  
It is believed that the 2 days of AIH treatment investigated in this thesis is near 
the minimum threshold of hypoxic cycle exposure needed to induce a significant 
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regenerative response in the peripheral nervous system, with more prolonged treatment 
perhaps capable of eliciting an even more beneficial effect. With increased exposure to 
AIH, such as the Satriotomo et al. (2012) protocol of three days of AIH treatment per 
week for 10 weeks, there is a significant elevation in the expression of VEGF, HIF-1α, as 
well as, BDNF, its receptor NTRK2 and the phosphorylated form of the NTRK2 receptor 
in non-respiratory alpha motor neurons (Satriotomo et al. 2016). A more aggressive 
protocol with respect to reduced oxygen levels (8%) AIH also elicited an approximate 
30% increase in expression levels of nuclear HIF-1α in L4 and L5 DRG compared to 
normoxia controls Cho et al. (2015). It is important to note that Cho et al. (2015) used the 
same surgical anesthesia as we did, isoflurane, which has been shown to increase levels 
of HIF-1α and inducible nitric oxide synthase mRNA in hippocampal neurons (Li, Zhu, 
and Jiang 2008). Only 2% of isoflurane anesthesia administered for 30 min, 24 hours 
prior to transient cerebral ischemia (stroke) was shown to be neuroprotective (Sun et al. 
2015). The neuroprotection preconditioned by isoflurane administration is dependent on 
nitric oxide synthase (Zhao and Zuo 2004) and upregulates HIF-1α mRNA in 
hippocampal neurons (Li, Zhu, and Jiang 2008). This suggests that the systemic effects of 
AIH treatment, notably the increased expression of HIF-1α, may be confounded when 
administered shortly after isoflurane anesthesia, as in Cho et al. (2015).  
While these responses are promising and consistent with our observed responses, 
it is still not known whether a threshold effect exists for sensory neurons relative to motor 
neurons in this response, as was observed for ES following peripheral nerve repair.  One 
hour ES treatment at time of nerve repair, the same time-frame employed in our current 
study, has previously been shown to elicit the most optimal regeneration response with 
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ES treatment duration extending beyond this being less beneficial (Geremia et al. 2007), 
in contrast with motor neurons where ES durations of one hour all the way up to 2 weeks 
all elicited an optimal regeneration response (Al-Majed et al. 2000). It remains to be 
determined whether there is a threshold effect for sensory neurons with respect to AIH 
treatment of injured peripheral nerves.  
Notably, the parameters of our current AIH protocol were influenced by clinical 
investigations of intermittent hypoxia to date that have shown beneficial physiological 
effects and utilized cycles with 9-14% hypoxic levels, a low number of cycles lasting 15 
sec to 4 min each, and less than an hour of total exposure time per session (reviewed in 
Mateika et al. 2015, Mateika and Sandhu 2011).  
 
5.3 Peripheral nerve regeneration  
 
There are strain differences in how the motor neurons contributing to the tibial 
nerve distribute segmentally.  Employing a combination of light and electron 
micrographs of naïve rat tibial nerve, taken just distal to the sciatic trifurcation, it was 
determined that 1000 motor, 3700 sympathetic, 3500 myelinated and 5400 unmyelinated 
sensory axons contribute to the tibial nerve of male Wistar rats (Schmalbruch 1986). The 
tibial nerve motor component was described as distributing to spinal segments L4 to L6. 
In comparison, the tibial nerve in Lewis rats, distributed within the upper two thirds of 
the lateral aspect of the ventral horn of the spinal cord from L3 to L5. Further, I identified 
that a total of 1150 +/- 296 (n=6) FG-labeled motor neurons contribute to the tibial nerve.  
This is roughly in line with the findings of other researchers, with 1144 +/- 163 motor 
neurons distributing from L1 to L6 (Yu et al. 2016) and 982 +/- 36 motor neurons from 
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L3 to L6 (Swett et al. 1986) found to contribute to the tibial nerve of adult female 
Sprague-Dawley rats. Thus, it appears that adult rats, irrespective of strain, have a total of 
~1000 to 1150 motor neurons in the tibial nerve, however their cell body spinal segment 
distribution may indeed be strain specific. 
 Schmalbruch (1986) counted a total of 8900 sensory axons in the tibial nerve. We 
observed the tibial from Lewis rats has the majority of its sensory nerve fibers 
distributing to the L4 DRG (unpublished findings) with 4514 +/- 363 cell bodies labeled 
(51% of the total number in the ganglia). Swett et al.’s (1991) extensive sciatic nerve 
branch analysis concluded that the L4 DRG contained 3234 +/- 1098 contributing to the 
tibial nerve from both male and female Sprague Dawley rats with wide weight variances 
(120-510 grams). Thus it appears it is difficult to do cross strain comparisons of numbers 
of DRG neurons contributing to the tibial nerve, as significant inter strain variability 
exists (Rigaud et al. 2008). There has also been a study published about the lack of 
morphological symmetry within individual rats with multiple observed variations of 
bilateral or unilateral thin nerves forming connections from L3 to L4 or L4 to L3 (Asato 
et al. 2000). 
 The tibial nerve, directly after the sciatic trifurcation, but proximal to its branch to 
the medial gastrocnemius muscle, by our assessment, contains axons from 1150 +/- 293 
motor neurons (n=6) and 4514 +/- 363 L4 DRG sensory neurons (n=6). We thus 
performed a tibial nerve injury repair at this location and 25 days later assessed the 
number of regenerating neurons contributing axons 28 +/- 1 mm distal to the repair site.  
This revealed that an average of 359 +/- 42 (Norm), 428 +/- 83 (AIH) and 478 +/- 120 
(ES) regenerating motor neurons and an average of 571 +/- 51 (Norm), 639 +/- 74 (AIH) 
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and 746 +/- 42 (ES) regenerating L4 DRG sensory neurons had regenerated to this point 
with no significant differences noted between treatment paradigms. It is of note that this 
location is distal to the tibial nerve branches to the medial gastrocnemius muscle, the 
lateral gastrocnemius, soleus and plantaris muscles, and the tibialis posterior, flexor 
halluces longus and the flexor digitorum longus muscles and would therefore contain 
significantly fewer axons. It should ultimately consist of the axons projecting to the two 
terminal branches of the tibial nerve: the medial plantar nerve and the lateral plantar 
nerve. Crockett, Harris, and Egger (1987) reported, in uninjured rats, ~180 motor neuron 
cell bodies located in caudal L5 and rostral L6 spinal levels contributing to the medial 
plantar nerve and ~310 motor neuron cell bodies distributed throughout L4 to L6 spinal 
levels contributing to the lateral plantar nerve. Therefore, this would indicate that roughly 
87% +/- 17% of motor neurons regenerated with AIH treatment and 97% +/- 24% with 
ES treatment, both treatments higher than the 73% +/- 9% motor neurons observed with 
Norm treatment in our model.  
 
5.4 Impact of AIH and ES treatment on behavioural and functional measures of 
regeneration 
 Lewis rats have been shown to have diminished hypothalamic-pituitary-adrenal 
axis activity and have an increased predisposition to developing autoimmunity and 
chronic inflammation in comparison with the Fischer 344 strain (Fecho and Valtschanoff 
2006). When Lewis rats are subjected to a partial sciatic nerve ligation, they develop 
profound mechanical hyperalgesia and no thermal hyperalgesia, while the Fischer 344 
strain acquired just the opposite, thermal hyperalgesia and no mechanical hyperalgesia. 
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Thus, our observations of no significant differences between the non-injured and injured 
hind paws in our Lewis rats with regards to thermal hyperalgesia after a tibial nerve 
transection for 10 weeks post-repair support Fecho and Valtschanoff (2006) strain-
specific findings. Correspondingly, significant differences in mechanical hyperalgesia 
were observed between the hind paws during both time points, 25 days and 10 weeks 
post-repair.  
 Nerve debridement, i.e. excision of a small portion of the proximal nerve stump, 
is recognized as an additional measure during surgery in humans to support nerve 
regeneration, especially in circumstances of delayed repair (reviewed in Hammert 2013). 
Modeled in rats as a conditioning lesion, it consists of damaging the nerve typically with 
a crush lesion, prior to the subsequent nerve injury. When assessed for its regenerative 
potential, a conditioning lesion has been shown to improve foot print spread as measured 
by sciatic functional index at 13 days compared to 18 days in non-conditioned rats (Bisby 
1985). Rats that had a conditioning lesion to the tibial nerve also had a significant long-
term reduction in hypersensitivity to thermal and mechanical stimuli compared to their 
non-injured hind paws (Moalem-Taylor et al. 2011). A conditioning lesion performed 3 
days prior to a nerve crush recently highlighted the role of HIF-1α as a transcriptional 
regulator, activating the pro-regenerative program, showing a 2 fold increase in axon 
regeneration (Cho et al. 2015). In our model, no conditioning lesion or nerve debridement 
was employed at the time of coaptation, as it was performed immediately following 
transection, a situation that does not exist in a clinical setting. This however permitted the 
quantification of functional outcomes associated with AIH or ES treatment 
unencumbered by the decrease or increase in regeneration potential seen in clinical 
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settings due to a number of varying factors including delay of repair, surrounding 
necrotic tissue, nerve debridement, regeneration distance as well as increased nerve 
tension among many others.  
We not only saw no significant differences in performance on the ladder crossing 
test between treatment groups by 10 weeks post-tibial nerve repair, but none fully 
recovered to baseline accuracy. The rats were observed attempting to avoid putting the 
right hind limb fully down when crossing, non-specifically affecting the accuracy of the 
placement of their forelimbs while balancing accordingly. An irregular pattern of ladder 
peg placement has been used previously for hind limb mobility assessment (Kemp et al. 
2010, Metz and Whishaw 2002) whereby the pegs are spaced between 1 to 5 cm from 
one another and the sequence is switched between each testing session. No behavioural 
improvement was seen until week 3 onward in the experimental groups compared to the 
negative control group (Kemp et al. 2010). It is believed that the additional spacing 
between the pegs and the variability in peg placement would have proven more 
challenging to the tibial injured rats in this study, such that variations in performance may 
have been more readily observed.  
With ES treatment, we observed a significant partial recovery of the toe spread 
from week 5 onward relative to normoxia treated rats and with AIH, at the week 6 and 
week 7 time-points, possibly due to reinnervation of the tibialis posterior, flexor hallucis 
longus and the flexor digitorum longus muscles, all contributing to supination of the foot, 
reversing the pathological pronation of the foot seen with a tibial nerve injury. Lewis rats 
with a tibial nerve repair significantly recover toe spread from 4 to 24 weeks, however 
they don’t fully recuperate; remaining significantly different from non-injured controls 
 123 
during all assessments from 2 to 24 weeks (Hare 1993). These muscles and the tibial 
nerve branches that innervate them are distal to the tibial nerve branches for the 
gastrocnemius, plantaris and soleus muscles that allow the rat to lift its hock, a kinematic 
variable that decreases print length and is affected by the velocity of the rat. Gait, stance 
duration and stride length are all factors altered by changes in a rat’s locomotion velocity 
(reviewed in Kemp, Cederna, and Midha 2017). Moradzadeh et al. (2008) also observed 
significant improvements at week 6 and week 7 in Lewis rats with a tibial nerve 
transection repaired with an acellular motor nerve graft compared to an acellular sensory 
nerve graft. However this was measured by a decrease in print length, not an increase in 
toe spread, potentially identifying when reinnervation of the more proximal 
gastrocnemius, plantaris and soleus muscles occurred, allowing the rat to effectively lift 
its hock post-surgery. Significant recovery of print length in Lewis rats occurs from 4 to 
24 weeks post-tibial nerve repair with maximal recovery reported to be at 16 weeks (Hare 
1993). This supports findings of ES treatment by Pockett and Gavin (1985) that showed 
with 1 Hz for 15 min to an hour, rats regained their toe spread reflex more quickly, from 
10.4 +/- 1.7 days without ES to 4.14 +/- 1.6 days with ES, after a sciatic nerve crush. 
Additionally, ES treatment has been compared to and combined with treadmill training as 
a therapy for peripheral nerve injuries in animals and shown to enhance the number of 
regenerating axon profiles in an androgen receptor-dependent manner (Thompson, 
Sengelaub, and English 2014). Gordon and Borschel (2016) have recently stated that 
“both ES and exercise are promising experimental treatments for peripheral nerve injury 
that seem to be ready to be translated to clinical use”. Thus there are a plethora of 
exciting possibilities to potentially improve peripheral nerve regeneration: ES could be 
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paired with surgery if performed, AIH could be administered as an inpatient or outpatient 
therapy and specific exercise could be included in rehabilitation protocols. 
 
5.5 Clinical relevance 
The findings in my thesis support the potential for AIH and ES treatment as viable 
therapies in supporting the regeneration of peripheral nerve injuries. We are aware that 
our treatment protocol of ES administered at the time of nerve repair, which in our case 
occurs immediately after a peripheral nerve injury, is not a clinically feasible timeline. 
However, at the clinical level, ES treatment has already shown to accelerate axonal 
regeneration when administered immediately following carpal tunnel release (Gordon et 
al. 2010, Gordon, Brushart, and Chan 2008). When applied to the proximal stump of an 
injured nerve and immediately repaired nerve, it enhances the regeneration of both 
sensory and motor neurons as well as their regrowth specificity (Geremia et al. 2007, Al-
Majed et al. 2000, Brushart et al. 2005). If treatment is further delayed, it has been 
shown, in animals, that ES remains a worthwhile treatment modality, increasing the 
numbers of both motor and sensory neurons when administered at the time of a peripheral 
direct nerve-to-nerve repair, three months after the initial injury (Elzinga et al. 2015). 
Thus, ES should be considered therapeutically pertinent to administer immediately 
following a peripheral nerve repair, whether it is days or months after the initial injury.  
Beyond direct nerve stimulation, stimulation of target tissue such as muscle is also being 
explored (Willand et al. 2016, Willand et al. 2015).  
AIH is also seemingly ready for the same bench to bedside transition, as a novel 
therapy for peripheral nerve injuries. Its affect on the central nervous system is currently 
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being investigated in long-term clinical trials in patients with partial spinal cord injuries 
(Clinical Trials Gov. #NCT02274116 and #NCT03071393) with promising initial 
findings. Additionally, 15 cycles of 90 second hypoxic episodes of 9% oxygen alternated 
with normoxic 21% oxygen (total time per treatment of 45 min) as a non-severe 5 
times/first week followed by 3 times/week for 3 weeks treatment protocol in humans has 
been demonstrated to not elicit any visual or verbal memory impairment during or after 
(Navarrete-Opazo et al. 2016). Our studies further support this translation to the clinical 
level of investigation with data demonstrating no deleterious effects on thermal or 
mechanical sensation of rat footpads. Notably, a new clinical trial is also examining 
sensory function in healthy adult humans with AIH (Clinical Trials Gov. 
#NCT03283072). Similar to the studies in animals describing outcomes with delayed ES 
treatment, our research group investigated AIH treatment administered 4 weeks after a 
partial spinal cord injury in a rat (Prosser-Loose et al. 2015). It was shown to improve 
forelimb function when combined with task training. After the successful completion of 
the clinical trials, it is fair to conclude that clinical inquiries into AIH’s effect on the 
peripheral nervous system should be the next logical step in establishing its potential as a 
non-invasive alternative to ES treatment for peripheral nerve injuries.  Finally, due to the 
systemic impacts of AIH, it is possible that the positive combinatorial impacts of ES and 
hypoxia on muscle responses associated with favorable repair described in Tang et al. 
(2004) and AIH on neuronal responses (current thesis; Cho et al. 2015), work in 
combination to promote the favorable impacts of AIH observed in this thesis on nerve 
regeneration.  In support of the potential for manipulation of both neuronal and target 
tissue to promote peripheral nerve regeneration outcomes, it has recently been shown that 
 126 
electrical muscle stimulation (Willand et al. 2015) and electrical nerve stimulation 
(reviewed in Gordon, Eva, and Borschel 2015) can both improve motor neuron 
regeneration, thus opening the avenue toward exploring combinatorial ES treatments. 
In the course of our experiments supporting a promising potential for AIH in 
enhancing nerve repair, we also gained insight into the biological variability in 
physiological response to AIH treatment, which indicates that not all people may respond 
in an equivalent manner to AIH. We observed no discernible alteration in the RAG 
response in initial studies of 1 or 2 day AIH performed on the Wistar strain of rat, a strain 
commonly used in the Verge lab to study nerve repair and the impact of ES.  Thus, we 
switched to the Lewis strain of rat used by Dr. Muir’s group, due to their consistent 
response to AIH treatment following central nervous system injuries and their calm 
disposition for behavioural work. Prominent research groups in the field of AIH primarily 
use an in-house Sprague Dawley strain and the Lewis strain of rats (Baker-Herman et al. 
2010, Lovett-Barr et al. 2012). Different inbred rat strains including Brown-Norway, 
Fischer, Lewis and Piebald-viral-Glaxo, showed differences in phrenic LTF responses 
with AIH (Golder et al. 2005). In humans, following AIH treatment, there appear to not 
be any sex differences in the observed increased magnitude of LTF minute ventilation, 
but depression of parasympathetic activity and increases in sympathovagal balance 
compared to baseline were found to be significantly different in men, but not women 
(Wadhwa et al. 2008). Some age, sex and hormone differences in the development of 
LTF after AIH have also been reported in rats (Zabka, Behan, and Mitchell 2001b, a, 
Zabka, Mitchell, and Behan 2006). Thus, careful documentation of phenotypic response, 
the potential variability in short-term and long-term effects, to AIH in future clinical trials 
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will help to establish dose parameters based on age, sex and hormone levels among other 
health markers. 
 
5.6 Conclusions and future directions  
In conclusion, we have shown that AIH mirrors many of the beneficial effects of 
electrical nerve stimulation on peripheral nerve repair outcomes, highlighting its potential 
for clinical translation as a non-invasive means to effect better regeneration of the injured 
peripheral nerve.  
AIH and ES treatment increased the expression of RAGs and showed some 
significant changes in regenerative capacity in a tibial nerve injury repair animal model. 
It has been argued that regeneration of the tibial nerve is difficult to assess in terms of the 
neuromuscular system as it innervates a large range of muscles having multiple functions 
in the hind limb (reviewed in Gordon and Borschel 2016). Thus, other clinically relevant 
peripheral nerve pathology models such as entrapment of the median nerve within the 
carpal tunnel, the ulnar nerve in the post-condylar groove or the sciatic nerve within the 
piriformis muscle could further elucidate the potential benefits of AIH and ES in fine 
motor movement and gross limb function.  
 Analysis of the motor neurons and sensory neurons as well as their axons that 
contribute to the regenerating tibial nerve 25 days after a tibial nerve repair provided 
insightful preliminary data on the potential reinnervation of the medial and plantar nerves 
and should be replicated to increase the total number of animals. FG was introduced 28 
+/- 1 mm from the repair site, which lies approximately 5 mm proximal to the bifurcation 
of the medial and lateral plantar nerves. The tibial nerve contributes the majority of the 
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innervation of the rat hind limb footpad via the medial and lateral plantar nerves. 
Limitations were observed in the footpad measurements presented given the decreased 
prints lengths erroneously selected for analysis. With further food reward encouragement, 
as rats increase their pace, they lift their hock thus decreasing their print length. This 
testing parameter modification could potentially provide future data for the early 
reinnervation of the gastrocnemius, plantaris and soleus muscles separate from the toe 
spread data we collected that more accurately represents the possible distal reinnervation 
of the tibialis posterior, flexor hallucis longus and the flexor digitorum longus muscles 
which all contribute to supination of the foot. In addition to future footprint analysis, 
collection and sectioning of the footpad could provide information regarding 
reinnervation. With respect to this, the regenerating nerve fiber types could be visualized 
with an ankyrin-b antibody, as Aβ and all of the cutaneous mechanoreceptor fibers 
including hair follicle receptors and Meissner and Pacinian corpuscles as well as Aδ and 
C fibers, express ankyrin-β at the axon terminals (Engelhardt et al. 2013). Thus, skin 
reinnervation could potentially be quantified in a spatial manner, proximal to distal. In 
addition to the suggested footprint analysis modifications and collecting supplementary 
sensory reinnervation data from the footpads, regenerative outcomes in the motor 
component of this model could also be further analysed with respect to quantifying re-
established neuromuscular junctions, muscle fiber size and muscle weights, as in Jonsson 
et al. (2013). 
An AIH protocol with more than 2 days of treatment should be examined to see if 
it further increases the demonstrated benefits on peripheral nerve regeneration to a level 
rivaling that seen with the more invasive ES treatment protocol, thereby making it a 
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viable treatment option. Repair strategies employed in this thesis could also be combined 
with those of Willand et al. (2015), which demonstrate an enhanced regenerative capacity 
in response to ES of target muscle. In this instance, the hypothesis to be tested would be 
that AIH coupled with ES of the nerve at the time of repair and ES of the target muscle 
would further improve functional outcomes after a peripheral nerve injury. Finally, the 
increasing numbers of clinical trials involving other nervous system pathologies speak to 
the promise of AIH as a therapeutic intervention and support the need for further research 
examining its potential in peripheral nerve repair. Current AIH-based clinical trials 
examine systemic inflammation and brain function imaging (Clinical Trials 
Gov.#NCT03453697), circulating progenitor cells and cognitive functioning in patients 
with traumatic brain injuries (#NCT02083445) and functional recovery in patients with 
partial spinal cord injuries (#NCT01272336, #NCT01272349, #NCT02274116, 
#NCT03071393, #NCT02973438, #NCT03433599, #NCT03262766).  
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